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Summary 
 
Ammoniagenesis occurs at the site of renal proximal tubule and is essential for 
correcting disturbances in acid-base homeostasis.  These disturbances can manifest with 
changes in diet, physical activity or during various disease states.  Glutamine is the 
critical substrate for renal ammoniagenesis and gluconeogenesis; each molecule of 
glutamine transported into the proximal tubule cell is ultimately converted into 
ammonium and bicarbonate, restoring systemic acid-base balance.  The sodium-coupled, 
neutral amino acid transporter, Slc38a3 (SNAT3) has been localized to the basolateral 
membrane of the proximal tubule cell and is purported to be the transport mechanism that 
allows glutamine entry into the cell to generate ammonium.  We have shown that 
SNAT3, as well as two important enzymes involved in renal ammoniagenesis and 
gluconeogenesis, namely phosphate-dependent glutaminase (PDG) and 
phosphoenolpyruvate carboxykinase (PEPCK) exhibit increased mRNA expression and 
protein levels after a dietary acid challenge.  Along this line, recent clinical studies have 
identified a link between type II diabetes mellitus and an increased prevalence of uric 
acid nephrolithiasis in humans.  These subjects have reduced renal ammonium excretion; 
however the etiology of these defects is unknown and may be related to defective 
ammoniagenesis and SNAT3 function or regulation. 
In lieu of these observations, the aim of this dissertation was thus three-fold.  
First, we sought to elucidate the role of SNAT3 in ammoniagenesis during potassium 
restriction or excess protein intake; two known effecters of acid-base homeostasis.  
Second, we created a murine model of diet-induced obesity to determine if an ensuing 
insulin-resistant state could alter renal ammoniagenesis, which could explain the 
development of nephrolithiasis and reported urinary changes in diabetic individuals. 
Third, we developed an ENU mutagenesis mouse model for SNAT3 in order to clarify 
the role of this transporter in vivo.   
Both potassium depletion and high dietary protein intake are known to elevate 
renal ammonium excretion.  For our first experimental aim, we examined SNAT3, 
phosphate-dependent glutaminase (PDG), and phosphoenolpyruvate carboxykinase 
(PEPCK) regulation during a control (0.36%) or low K+ (0.02%) diet for 7 or 14 days; or 
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a control (20%) or high protein (50%) diet for 7 days.  Metabolic acidosis was induced in 
control and low K+ groups by administration of NH4Cl to the drinking water.  We 
observed that urinary ammonium excretion increased during metabolic acidosis, K+ 
restriction alone after 14 days, and during high protein intake.  SNAT3, PDG and PEPCK 
mRNA abundance was elevated in metabolic acidosis and 14 day K+ restriction but not 
during high protein intake.  SNAT3 protein abundance was enhanced during metabolic 
acidosis (both control and low K+), 14 day low K+ treatment alone, and during high 
protein intake.  Seven day dietary K+ depletion alone had no effect.  
Immunohistochemical studies showed SNAT3 staining in earlier parts of the proximal 
tubule during 14 day K+ restriction with or without NH4Cl treatment and during high 
protein intake.  In sum, chronic dietary K+ restriction, high protein intake and metabolic 
acidosis enhance ammoniagenesis paralleled by increased SNAT3 expression. 
To further investigate the role of SNAT3 during renal ammoniagenesis, we 
employed a murine model of diet-induced obesity for our second aim.  The study design 
was based on reports that the prevalence of uric acid nephrolithiasis among patients with 
type 2 diabetes and metabolic syndrome is highly correlated with a more acidic urine and 
lower urinary ammonium excretion; the etiology is likely associated with insulin 
resistance.  Insulin has been shown to stimulate ammoniagenesis in renal cell lines, 
possibly via increased phosphate-dependent glutaminase (PDG) activity and glutamine 
metabolism.  We placed C57BL6 mice on either a control (standard mouse chow) or 
“cafeteria” style diet for 10 weeks to induce obesity and insulin resistance.  
Intraperitoneal glucose tolerance tests (IPGTT) were performed and animals were 
subsequently assigned to various groups: control with normal IPGTT; obese, glucose-
intolerant animals with abnormal IPGTT (O-GI); or moderate weight animals with 
normal IPGTT (Non-Responders, NR).  Groups were divided into subgroups and NH4Cl 
was added to the food for the final 48 h.  We found that basal urinary ammonium 
excretion was unremarkable among groups.  Providing an acid challenge with NH4Cl 
increased urinary ammonium excretion in all groups, but to a lesser extent in the O-GI 
group.  SNAT3 mRNA expression was remarkably enhanced in both cafeteria-diet 
treated groups.  PDG expression was strongly elevated only in the O-GI group given 
NH4Cl, whereas PEPCK was enhanced in both O-GI and NR groups given NH4Cl.  
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Na+/H+ Exchanger (NHE) activity in the brush border membrane of the proximal tubule 
was strongly reduced in the O-IR group indicative of a lower capacity to excrete 
ammonium.  These data suggest that obesity and insulin resistance impairs renal 
ammonium excretion in response to NH4Cl feeding through reduced NHE3 activity. 
Upregulation of SNAT3 and ammoniagenic enzymes suggest a possible compensatory 
mechanism involved in O-GI mice. 
 Our interest in characterizing the role of SNAT3 during renal ammoniagenesis 
and metabolic acidosis led us to develop a novel genetic mouse model to clarify the role 
of SNAT3 in vivo.  Male mice were treated with the potent mutagen N-ethyl-N-
nitrosourea (ENU), resulting in offspring carrying a single nucleotide polymorphism (“C” 
to “T” mutation) known as “SLC38a3-Q263X”.  This mutation creates a premature stop 
codon deleting the second half of the SNAT3 protein.  A total of 52 pups from five litters 
have been analyzed for this study.  Pups were sacrificed between postnatal-day 15-18, 
since mutant mice died shortly thereafter.  Tissues, serum and urine were collected and 
analyzed.     
SNAT3 protein abundance in both kidney and liver was undetectable in mutant 
mice using antibodies directed towards both the C- and N-terminus of the SNAT3 
protein, demonstrating that the mutation indeed leads to ablation of the protein.  Mutant 
mice weighed less than littermates, exhibited reduced urinary NH4+ and urea excretion 
and had elevated serum urea.  Renal SNAT3 mRNA expression was significantly lower 
in mutants, while PDG and PEPCK mRNA expression remained unchanged.  Mutant 
mice showed enhanced PDG protein levels, while PEPCK remained unchanged in 
kidney.    
Interestingly, heterozygous mice showed reduced renal and hepatic SNAT3 
protein levels in comparison to wildtype mice; this prompted further investigation.  After 
an NH4Cl acid challenge, heterozygous mice showed enhanced SNAT3, PDG and 
PEPCK mRNA expression, however no changes were observed in NHE3 activity, the 
apical NH4+ efflux pathway in the proximal tubule.   
These data suggest that the absence of functional SNAT3 is lethal in mice. Mutant 
mice are smaller, display abnormal neurological behavior, and have altered regulation of 
renal ammoniagenic/gluconeogenic enzymes as well as reduced urinary ammonium and 
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urea excretion.  Heterozygous mice showed regulatory changes in SNAT3, PDG and 
PEPCK, perhaps as a compensatory mechanism to account for the partial defect in 
SNAT3. 
In conclusion, the data presented herein show strong evidence that SNAT3 is 
likely the glutamine influx mechanism in renal proximal tubule cells for the production of 
ammonia.     
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Deutsche Zusammenfassung der Doktorarbeit 
 
Der proximale Tubuls synthetisiert Ammonium, das essentiell für die Korrektur 
von Säure-Basenstörungen ist. Solche Störungen treten auf infolge Veränerungen in der 
Diät, der körperlichen Aktivität oder während verschiedener Erkrankungen. Glutamin 
dient als Substrat für die renale Ammoniagenese und auch Glukoneogenese, aus jedem 
Molekül Glutamin, das in die Zellen des proximalen Tubulus aufgenommen worden ist, 
kann nach Ammonium und Bikarbonat enstehen und damit die Säure-Basenbalance 
wiederhergestellt werden. 
Der Natrium-gekoppelte Aminosäuretransporter Slc38a3 (SNAT3) wurde an der 
basolateralen Membran des proximalen Tubulus lokalisiert und gilt als Kandidat für die 
Aufnahme von Glutamin in die Zelle für Ammoniagenese. Wir haben bereits gezeigt, 
dass SNAT3 und zwei wichtige Enzyme der Ammoniagenese und Glukoneogenese, die 
Phosphat-abhängige Glutaminase (PDG) und die Phosphoenolpyruvatkarboxykinase 
(PEPCK), verstärkt exprimiert werden unter einer Säurebelastung. In die gleiche 
Richtung gehend, haben verschiedene neuere klinische Studien gezeigt, dass es eine 
Korrelation zwischen Typ II Diabetes und dem erhöhten Auftreten von Uratnierensteinen 
bei Patienten besteht. Diese Patienten haben eine verminderte Ammoniumausscheidung 
im Urin, allerdings ist die Ursache für diesen Defekt nicht bekannt, ein Zusammenhang 
mit veränderter Ammoniagenese und SNAT3 Funktion oder Regulation ist möglich. 
Aufgrund dieser Beoachtungen hatte die vorliegende Dissertation drei Ziele. Erstens 
versuchten wir die Rolle von SNAT3 während vermehrter Ammoniagenese stimuliert 
durch Kaliumrestriktion oder vermehrter Eiweisszufuhr zu klären. Zweitens, wollten wir 
ein Mausmodell für Diät-induzierte Adipositas etablieren um zu testen, inwiefern ein 
Insulin-resistenter Zustand die renale Ammoniagenese beeinflusst um zu sehen, ob dies 
das vermehrte Auftreten von Uratnierensteinen bei Diabetikern miterklären könnte. Als 
drittes Ziel, charakterisierten wir ein durch NEU-Mutagenese enstandenes Mausmodell 
defizient für SNAT3 um die Funktion dieses Transporters in vivo zu untersuchen.  
Sowohl Kaliumrestriktion als auch Proteinzufuhr verusachen erhöhte 
Ammoniumausscheidung. Im ersten Teilprojekt untersuchten wir SNAT3, PDG und 
PEPCK während einer Kontrolldiät  (0.36% Kalium) oder einer Niedrigkaliumdiät 
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(0.02% Kalium) für 7 oder 14 Tage. Ausserdem wurde noch in einer Subgruppe 
metabolische Azidose durch die Gabe von NH4Cl im Trinkwasser verursacht. Die renale 
Ammoniumausscheidung wurde stimuliert während metabolischer Azidose und 
Kaliumreskrition für 14 Tage, sowie durch Proteinzufuhr. SNAT3, PDG und PEPCK 
mRNA Expression wurde erhöht durch metabolische Azidose und Kaliumrestriktion, 
nicht aber durch Proteinzufuhr. Die Proteinexpression von SNAT3 war vermehrt 
während metabolischer Azidose, 14 Tage Kaliumrestriktion und durch proteinzufuhr. 
Eine 7-tägige Kaliumrestriktion hatte keine Wirkung. Immunhistochemie zeigte, dass 
SNAT3 auch in den früheren Anteilen des proximalen Tubulus exprimiert wurde 
während dieser Maneuver. Zusammenfassend lässt sich sagen, dass die erhöhte 
Ammoniagenese und Ausscheidung in diesen Situation mit der erhöhten SNAT3 
Expression korreliert. 
Um die Rolle von SNAT3 in der renalen Ammoniagenese im zweiten Teilprojekt 
weiter zu untersuchen, entwickelten wir ein Mausmodell für Diät-induzierte Adipositas. 
Diese Studie basiert auf der Beobachtung, dass das Auftreten von Uratnierensteinen bei 
Patienten mit Typ II Daibetes und metabolischem Syndrom sehr stark korreliert mit 
einem sauren Urin pH und niedriger Ammoniumausscheidung. Die Ursache ist 
vermutlich Insulinresistenz. Insulin stimuliert in renalen Zelllinien die Ammoniagenese, 
vermutlich via vermehrte PDG Aktivität und erhöhten Glutaminmetabolismus. C57BL6 
Mäuse erhielten entweder eine Standarddiät oder eine “Cafeteria” Diät für 10 Wochen 
um Adipositas und Insulinresistenz zu induzieren. Ein intraperitonealer 
Glukosetoleranztest (IPGTT) wurde durchgeführt und die Tiere anschliessend in 
verschiedene Gruppen eingeteilt: Kontrolltiere mit normalen IPGTT; obese, glucose-
intolerant (adipöse, Glukose-intolerante) Tiere mit pathologischem IPGTT (O-GI); oder 
Tiere mit moderatem Gewichtsanstieg und normalen IPGTT (Non-Responders, NR).  
Diese drei Gruppen wurden weiter unterteilt und jeweils die eine Hälfte noch zusätzlich 
mit NH4Cl im Futter für die letzten 48 Stunden behandelt. Die basale 
Ammoniumausscheidung war in allen Gruppen gleich. Jedoch die Gabe von NH4Cl 
verusachte in der O-GI Gruppe einen geringeren Ammoniumanstieg im Urin.  SNAT3 
mRNA Expression war deutlich erhöht in den Cafeteria-Diät Gruppen. PDG mRNA 
Expression war deutlich erhöht, aber nur in der O-GI Gruppe, während PEPCK erhöht 
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war in beiden O-GI und NR Gruppen unter NH4Cl Gabe.  Na+/H+ Austauscher (NHE) 
Aktivität in der Bürstensaummembran des proximalen Tubulus war deutlich reduziert in 
der O-IR Gruppe, ein Hinweis auf einer verminderte Kapazität Ammonium 
auszuscheiden. Diese Daten deuten darauf hin, dass Adipositas und Insulinresistenz die 
renale Ammoniumausscheidung bei NH4Cl Beladung vermindert. Die erhöhte Expression 
von SNAT3 und der Ammonigeneseenzyme deuten auf einen kompensatorischen 
Mechanismus hin. 
 Im dritten Teilprojekt charakterisierten wir eine neue genetisch veränderte Maus 
um die Rolle von SNAT3 in der renalen Ammoniagenese und während metabolsicher 
Azidose zu untersuchen. Männliche Mäuse wurden mit dem potenten Mutagen N-ethyl-
N-nitrosourea (ENU) behandelt. Dies führte dazu, dass die Nachfahren einen „single 
nucleotide polymorphism“ (“C” zu “T”) tragen, auch “SLC38a3-Q263X” benannt. Diese 
Mutation führt zu einem vorzeitigen Stopkodon, das die zweite Hälfte des SNAT3 
Protein entfernt. Wir untersuchten insgesamt 52 junge Mäuse aus 5 Würfen.  Die jungen 
Mäuse wurden zwischen dem 15. Und 18. postnatalen Tag getötet, da die mutierten 
Mäusen kurze Zeit spatter starben. Gewebe, Urin und Blut wurde gesammelt und 
untersucht. Das SNAT3 Protein konnte in Niere und Leber mittels Antikörper gegen den 
Karboxy oder Amino-terminus nicht entdeckt werden, ein Nachweis, das die Mutation 
zum Verlust des SNAT3 Proteins führt. Mutierte Mäuse hatten ein niedrigeres Gewicht 
als Geschwister, eine niedrigere Ammonium- und Harnstoffausscheidung im Urin und 
erhöhte Serumharnstoffwerte. Die renale SNAT3 mRNA Expression war reduziert, 
während PDF und PEPCK mRNA Expression normal waren. Allerdings hatten mutierte 
Mäuse eine erhöhte PDG Proteinexpression, die PEPCK Proteinexpression blieb normal. 
Interessanterweise hatten heterozygote Mäuse eine reduzierte renale und 
hepatische SNAT3 Proteinexpression. Daher untersuchten wir die Folgen einer 
Säurebeladung mit NH4Cl. Heterozygote Mäuse hatten eine erhöhte SNAT3, PDG und 
PEPCK mRNA Expression, die NHE3 Aktivität war jedoch unverändert. 
Unsere Daten zeigen, dass das Fehlen von SNAT3 in Mäusen lethal ist. SNAT3 
defiziente Mäuse haben ein vermindertes Wachstum, neurologische Störungen und eine 
veränderte renale Ammoniagenese und Gluconeogenese sowie eine reduzierte 
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Ammonium- und Harnstoffauscheidung. Heterozygote Mäuse haben vermutlich 
kompensatorischen Aenderungen in SNAT3, PDG und PEPCK Expression. 
Zusammenfassend deuten unsere Daten sehr stark darauf hin, dass SNAT3 
vermutlich die Aufnahme von Glutamin für die renale Ammoniagenese vermittelt. 
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I. Introduction: Renal ammoniagenesis 
 
Control of acid-base balance is a homeostatic mechanism that involves a highly 
intricate balance of organ systems.  Diet composition can largely influence the control of 
acid-base balance.  For example, excess protein intake associated with a western-type 
diet, results in a nonvolatile acid load secondary to the increased intake of sulphur-
containing amino acids (51).  On the other hand, volatile weak acids such as carbonic 
acid can dissociate to carbon dioxide (CO2) and water, or, in the presence of carbonic 
anhydrase, be readily converted to protons (H+) and bicarbonate (HCO3).  The CO2 
produced is removed through exhalation by the lungs, but nonvolatile acids cannot be 
excreted in this manner, so another regulatory mechanism must be in place.   
The kidney is the major organ responsible for removal of nonvolatile acid loads, 
which is accomplished by the generation and secretion of ammonium (NH4+, bicarbonate 
(HCO3) and H+ from the amino acid substrate, glutamine.  Regulation of acid-base 
homeostasis is highly dependent upon circulating concentrations of glutamine.  
Glutamine is a conditionally essential amino acid that is found in abundant quantities in 
the blood and cerebrospinal fluid.  It is critical for central nervous system 
neurotransmission, hepatic detoxification of ammonia into urea, and renal 
ammoniagenesis.  During metabolic acidosis, glutamine is released from various organs 
and shunted to the kidney in order to produce the ammonium required to buffer 
physiological acids.  
Ammoniagenesis occurs principally in the proximal tubule cell, which houses all 
of the necessary transport mechanisms involved in NH4+, HCO3 and H+ production and 
excretion.  The process of ammoniagenesis begins with glutamine entry from the blood 
into the proximal tubule cell cytosol.  A mitochondrial glutamine transporter, which is in 
fact an electroneutral uniporter, shuttles glutamine into the mitochondrial matrix, where it 
is rapidly converted to glutamate following an enzymatic reaction involving phosphate-
dependent glutaminase (PDG) (58, 122).  This process results in the liberation of one 
molecule of NH4+.  Glutamate is then further metabolized either through transamination 
or via glutamate dehydrogenase to yield α-ketoglutarate (31, 97).  This metabolic 
substrate can be shuttled into the tricarboxylic acid cycle or the gluconeogenic pathway 
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whereby cytosolic phosphoenolpyruvate carboxykinase (PEPCK), a key enzyme of 
gluconeogenesis, converts α-ketoglutarate to glucose and two bicarbonate molecules  (31, 
97).  Thus, PDG and PEPCK are important regulators of ammoniagenesis during 
metabolic acidosis (3, 32, 38).  The bicarbonate molecules generated from these 
processes help to partially alleviate acidosis after release into the blood, while the NH4+ is 
excreted into the urine, ultimately restoring systemic pH.   
 
 
 
 
 
 
 
Figure 1.  Renal proximal tubule cell model.  SNAT3 is localized to the basolateral aspect and participates 
in glutamine influx.  Mitochondrial PDG, glutamate dehydrogenase and PEPCK are involved in conversion 
of glutamine to CO2 or glucose. These enzymatic reactions generate two molecules of NH4+ and HCO3. 
α-ketoglutarate (αKG); Glutamine (Gln); Glutamate (Glu); Glutamate dehydrogenase (GDH); phosphate-
dependent glutaminase (PDG); phosphoenolpyruvate carboxykinase (PEPCK); Na+/H+ Exchanger isoform 
3 (NHE3).   
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II. Regulation of renal ammonium production 
 
Regulation of ammoniagenesis is indeed complex and involves several different 
mechanisms.  Both acute and chronic acidosis and alkalosis, potassium restriction, 
changes in luminal flow rate, and hormones such as angiotensin II, insulin, parathyroid 
hormone and prostaglandins can alter ammoniagenesis.   
Metabolic acidosis is one important pathological driving force for increased renal 
ammonium production.  Glutamine is shunted to the kidney rather than visceral organs 
leading to a substantial increase in renal glutamine extraction from blood and uptake into 
the proximal tubule cell during chronic acidosis (35, 125, 149).  Transport of glutamine 
into the proximal tubule cell cytosol is purported to occur via the basolaterally-located, 
sodium-coupled, neutral amino acid transporter Slc38a3 (SNAT3).  Protein and mRNA 
abundance of SNAT3 increases substantially in response to an acid challenge given as 
NH4Cl (68, 91, 102, 127).   
Along this line, renal catabolism of glutamine is also enhanced during metabolic 
acidosis.  This occurs primarily via enhanced ammoniagenic and gluconeogenic enzyme 
activity, namely PDG and PEPCK (34, 57, 112, 113, 152)  PDG is responsible for the 
catabolism of glutamine to glutamate, while PEPCK converts α-ketoglutarate into 
glucose and bicarbonate.  The mechanism by which these enzymes exert their effects, 
however, differs greatly.  PDG has been shown to increase in response to metabolic 
acidosis as a result of increased stabilization of its mRNA secondary to the binding of ξ-
crystallin/NADPH:quinone reductase to a pH responsive AU-rich region in the 3’ 
untranslated region of its mRNA (52, 78, 79).   PEPCK, on the other hand, shows 
increased enzyme activity via increases in PEPCK transcription as well as mRNA 
stabilization (57, 59, 60). 
Alkalosis, in contrast to acidosis, exerts an inhibitory effect on ammonia 
production and excretion.  The effects appear to be primarily associated with a reduction 
in ammoniagenic and gluconeogenic enzyme activity, affecting ammonia production (80, 
81, 108). 
Hormones can also regulate renal ammonia production.  Parathyroid hormone 
(PTH) has been shown to inhibit HCO3 absorption in the proximal tubule, as well as 
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inhibit Na+/H+ Exchanger isoform 3 (NHE3) activity, ultimately reducing luminal NH4+ 
transport (11, 64, 109).  Insulin administration has been shown to increase NHE3 activity 
and stimulate ammoniagenesis and excretion (26, 77).  Angiotensin II can stimulate renal 
ammoniagenesis, which may involve changes in intracellular calcium concentration and 
activation of a calcium-calmodulin dependent pathway (27, 93, 95, 98).  Glucocorticoids 
play a role in the response to acidosis by increasing glutamine fluxes to the kidney as 
well as enhancing NHE3 activity via increases in mRNA expression (75, 148).  
Activation of NHE3 activity has been shown to occur prior to changes on the protein 
level and involves trafficking to the apical membrane in opossum kidney cells (OKP) (14, 
146).  Additionally, there is evidence suggesting that glucocorticoid levels increase 
during metabolic acidosis (85, 147).  A recent study by Karinch et al. demonstrated the 
effect of glucocorticoids on SNAT3 regulation.  They showed that adrenalectomized rats 
exhibited a reduction in SNAT3 mRNA during metabolic acidosis which was partially 
compensated for by dexamethasone administration.  In contrast, sham-operated rats given 
the glucocorticoids inhibitor RU486 attenuated the increase in SNAT3 mRNA normally 
associated with metabolic acidosis (67).   
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III. Renal ammonium handling   
  
The nephron is organized in a series of segments that have different functions and 
transport properties in terms of ammonium excretion and absorption.  This chapter will 
summarize the various transport mechanisms involved in renal ammonium handling.    
 
III. 1 The Proximal Tubule 
 
The proximal tubule is the principal site of ammoniagenesis, occurring primarily 
in the proximal tubule cell mitochondria, with excretion into the tubular lumen.  In the 
presence of glutamine, metabolic acidosis increases ammonia production in the S1, S2, 
and S3 segments of the proximal tubule.  Metabolic alkalosis, on the other hand, 
produces a reduction in ammoniagenesis (43). Since the intracellular proximal tubule cell 
pH is roughly 7.2, most of the ammonia produced combines with H+ to form NH4+, due to 
the high pKa of this molecule (~pH 9), and subsequently this NH4+  must be secreted into 
the tubular lumen in order to buffer acids.  A once widely accepted theory of ammonium 
excretion is largely derived from the work done by Pitts et al. and is so coined the 
“diffusion trapping” theory (107).  This theory explains that in fact, there are no NH3 
gradients, such that NH3 concentrations do not change within the nephron.  Further, this 
model suggests that NH4+ cannot readily permeate cells and that its concentration is equal 
to that of circulating H+.  Pitts hypothesized that NH3 synthesized from glutamine 
diffuses into the proximal tubule lumen, only to combine with H+ in the luminal fluid; no 
mention of alternative transport mechanisms were inferred from his work. 
 The current body of data suggests that indeed proximal tubule NH4+ handling is 
much more complex.  Although NH3 diffusion is still widely accepted, NH4+ can also be 
transported into the lumen of the proximal tubule.  The apical Na+/H+ Exchanger (NHE) 
isoform 3 has been shown to transport NH4+ in exchange for Na+.  Evidence for this is 
based on work in rabbit renal microvillus membrane vesicles, whereby 22Na uptake was 
stimulated by NH4+ administration, suggesting that NH4+ can be transported by NHE, 
perhaps in place of H+ (74). Further, apical ammonia secretion is inhibited when luminal 
Na+ concentrations are reduced and with the addition of a specific inhibitor of NHE 
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activity in isolated perfused mouse proximal tubules (92, 96).  Conditions that enhance 
ammoniagenesis, such as metabolic acidosis, potassium depletion and changes in the 
hormone, angiotensin II, have been shown to alter NHE3 expression and activity, 
providing more evidence in support of NHE3-mediated, proximal tubular NH4+ secretion 
(4, 94, 99).     
 Apical membrane K+ channels are also present in the proximal tubule, and it has 
been observed that NH4+ can bind in place of K+ (28), suggesting that perhaps these 
channels could function in NH4+  secretion.  However, it is more likely that these channels 
have a greater role in the maintenance of proximal tubule cell membrane potential than 
NH4+ excretion (140).  
 
III.2 The Loop of Henle 
 
The loop of Henle, particularly the thick ascending limb (TAL) is the site of most 
of the NH4+ reabsorption, amounting to nearly 80% of all NH4+ delivered to this nephron 
segment (18, 119).  Ammonium reabsorption by this segment is necessary in order to 
establish an equilibration between luminal and medullary interstitial NH4+, which is 
subsequently transported into the collecting ducts and ultimately into the final urine. In 
the TAL, the apical Na+-K+-2Cl- cotransporter (NKCC2) is responsible for most of the 
NH4+ reabsorption, and occurs via competition of NH4+ for K+ (42).  During metabolic 
acidosis, enhanced medullary TAL NH4+ reabsorption occurs via increased NKCC2 
mRNA and protein expression, and this increase is secondary to stabilization of NKCC2 
mRNA (9, 66).    
Apical NHE3 activity has also been detected in this segment, however, since the 
primary function of the TAL is to reabsorb NH4+, NHE3 activity is probably not related 
to NH4+ reabsorption, but may play a role in regulation of intracellular pH secondary to 
greater influxes of NH4+ (44).  Metabolic acidosis also enhances NHE3 mRNA and 
protein levels in the TAL, however the reason for this upregulation has not been 
elucidated but may involve concomitant HCO3 reabsorption that is associated with 
acidosis (76).   
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III.3 The Collecting Duct  
 
This nephron segment conducts NH4+ excretion into the final urine and is 
associated with acidification of the lumen.  In both rats and rabbits, an acid 
disequilibrium pH is generated as a result of absence of carbonic anhydrase in the lumen, 
ultimately enhancing luminal NH3 secretion (76, 130).  Further, metabolic acidosis leads 
to increased NH4+ secretion in the collecting duct system (119).  There is evidence 
suggesting that basolateral NH4+ uptake into the collecting duct cells from the medullary 
interstitium occurs via NH4+  substitution for K+ on NKCC1 and Na+-K+-ATPase (144, 
145).  
Rhesus-like glycoproteins have recently been identified as potential candidates for 
collecting duct NH4+ transport.  The Rh B glycoprotein (Rhbg) and Rh C glycoprotein 
(Rhcg) isoforms have been localized to the basolateral and apical membranes of the 
collecting duct cells, respectively (39, 110, 142).   The Rhcg protein has recently been 
studied in a mutant mouse model (13).  Rhcg mutant mice fed a control diet showed a 
decrease in urinary NH4+ excretion and a more alkaline urinary pH.  Acid-loading these 
mice revealed reduced NH4+ excretion despite normal ammoniagenesis, suggesting NH4+ 
transport into the final urine has been affected by deletion of Rhcg (13).  Microperfusion 
experiments demonstrated reduced luminal NH3 permeability suggesting that Rhcg is 
critical for NH3 secretion. Therefore, Rhcg is crucial for ammonium excretion by the 
collecting duct in contrast to studies in an Rhbg mutant mouse model where no 
phenotype was observed (22).   
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Figure 2.  Renal ammonium transport in the nephron.  SNAT3 localized to the basolateral aspect of the 
proximal tubule cell transports glutamine into the cytosol for ammoniagenesis. NH4+ is either transported 
via NHE3 into the lumen or as ammonia via diffusion through the apical membrane. After pooling in the 
medullary interstitium, NH4+ is absorbed via NKCC2 in the TAL. NH4+ is secreted into the final urine is a 
result of apical Rhcg activity. Proximal convoluted tubule (PCT); proximal straight tubule (PST); loop of 
Henle (LH); medullary thick ascending limb (MTAL); cortical collecting duct (CCD); outer and inner 
medullary collecting duct (OMCD, IMCD). Modified from Seldin and Giebisch’s The Kidney 2008. 
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IV. Potassium restriction, high protein intake and metabolic acidosis increase 
expression of the glutamine transporter SNAT3 (Slc38a3) in mouse kidney 
 
IV.1 Dietary effecters of acid-base homeostasis 
 
Dietary potassium (K+) restriction and high protein intake affect acid-base 
homeostasis.  Studies in both animals and humans have observed enhanced renal 
ammoniagenesis, ammonium and acid excretion, and subsequently development of a mild 
alkalosis-like state during dietary K+ depletion (61, 88, 123, 135, 136).  In isolated mouse 
and rat renal proximal tubules, K+ restriction stimulates gluconeogenesis and ammonium 
production (94, 101).   
Potassium depletion leads to metabolic alkalosis and acidification of the urine, 
while causing a concomitant intracellular acidification (2).  Using 31Phosphorus-nuclear 
magnetic resonance imaging spectroscopy, Adam et al. determined that potassium 
restriction caused a substantial drop in intracellular pH without eliciting an extracellular 
acidosis (2).   The reduction in intracellular pH associated with K+ restriction emulates an 
acidosis-like state due to changes in a variety of proximal tubule acid-base regulatory 
mechanisms.  HCO3 absorption in the proximal tubules of K+ restricted rats increases 
substantially in comparison to controls (23).  This increase in HCO3 absorption is 
proposed to be secondary to increased basolateral Na+/3HCO3 cotransporter and the 
apical Na+/H+ Exchanger activity induced by dietary K+ depletion (128).  Further, OKP 
cells incubated in low K+ media showed a reduction in intracellular pH and a concomitant 
increase in NHE3 activity, similar to increases in NHE3 activity observed during 
metabolic acidosis (5). Interestingly, changes in both NHE3 mRNA and protein 
abundances did not follow a time-specific pattern and therefore suggest that variable 
regulation of this protein in the kidney, possibly via a tyrosine-kinase related mechanism 
(5) .      
K+ depletion is also associated with increases in bicarbonate reabsorption in the 
distal tubule, which appears to involve regulation of H+/K+-ATPases (6, 20, 21, 49, 151).  
Alternatively, H+-ATPase membrane insertion and activity in the collecting duct was also 
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found to be enhanced during K+ restriction, suggesting enhanced H+ secretion in the 
collection duct system (10, 131, 132).  
High dietary protein intake in the form of casein causes increased net renal acid 
and NH4+ excretion, suggesting that metabolism of sulfur-containing amino acids elicits 
the observed effects on acid-base handling (115, 150).  These alterations in acid–base 
homeostasis were also observed in studies using in vivo microperfusion techniques; a diet 
containing 50% casein resulted in increased net renal acid and NH4+ excretion, due in 
part to enhanced Na+/H+ exchanger, H+-ATPase, and endothelin-1 activities (69).  Excess 
dietary protein given as casein showed remarkable increases in distal nephron 
acidification in an endothelin-stimulated mechanism.  Endothelin stimulation increases 
both Na+/H+ Exchanger and aldosterone-induced H+-ATPase activity (70).  High protein 
intake is associated with increased salt reabsorption in the TAL via increased Na+/K+-
ATPase activity; the effect may be related to increased blood levels of aldosterone 
observed after high protein intake (126).         
 
IV.2 Amino acid transporters involved in acid-base balance 
 
In order for cells to utilize glutamine, specialized molecular transport mechanisms 
must be in place to allow for glutamine influx and efflux.  Much work in the area of 
amino acid transport proteins has led to the identification of a number of highly 
specialized transport systems in non-epithelial and epithelial cells (29, 30, 155).  The 
sodium-coupled neutral amino acid transporters of the SLC38 family are a group of 
system A and N transporters.  Members that are associated with System A transport 
include SNAT1, SNAT2 and SNAT4, while members exhibiting System N transport 
activities include SNAT3 and SNAT5.  These System N transporters also exhibit H+ 
countertransport and can operate in a multi-directional fashion. 
The SLC38 family was initially discovered by cloning of SNAT3 and SNAT1, 
secondary to their similar sequence identity with the vesicular inhibitory amino acid 
transporter (VIAAT, vesicular GABA transporter) (25, 45, 141).  VIAAT has been 
identified as an important transporter involved in synaptic vesicular exocytosis of the 
neurotransmitters glycine and GABA in central inhibitory neurons (86, 118).  Chaudhry 
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was the first to functionally identify SNAT3 (formerly SN1), and showed that it involved 
Na+ cotransport and proton exchange, and can mediate glutamine influx or efflux.   
The SLC38 family members fall into two categories; having either System A or N 
functional characteristics.  Both systems exhibit Na+-dependent transport of zwitterionic 
neutral amino acids, with System N having fewer amino acid substrates than System A.  
The members of the SLC38 family belonging to the System A subfamily include SNAT1, 
SNAT2, and SNAT4.  Members of System N include SNAT3 and SNAT5, and prefer 
glutamine, histidine and asparagine as transport substrates.   Interestingly, System A 
subtypes exhibit cotransport with Na+, while System N participates in  Na+ cotransport 
with H+ antiport. 
SNAT3 is highly expressed in brain astrocytes and retina, and has also been 
detected in liver, kidney, heart, skeletal muscle and in adipose tissue in varying degrees 
of mRNA and protein abundances (25, 45, 141).  SNAT3 performs electroneutral amino 
acid transport with a stoichiometry of 1 Na+ : 1 glutamine with antiport of 1 H+ (17, 24, 
25).  Studies of System N transport properties show that SNAT3 preferentially chooses 
glutamine as a substrate for transport (73).  Previous data has detected inwardly-directed 
currents in the presence of glutamine, asparagine or histidine in Xenopus oocytes 
expressing SNAT3 (41).  These currents show Na+ dependence and are also Li+ sensitive, 
a key characteristic of System N transport.  Interestingly, SNAT1 and 2 (System A), 
mediate electrogenic and not electroneutral transport, but lack an H+ antiport mechanism 
that is observed with SNAT3, suggesting a glutamine uptake rather than efflux 
mechanism associated with System A transport (24, 114, 133).  Interestingly, the H+ 
antiport mechanism appears to be a competitive inhibition of activation by Na+, similar to 
SNAT1 and SNAT2.  However with SNAT3, Na+ binding elicits amino acid uptake, 
while H+ binding elicits efflux.  Thus the transport mechanism involves a built in 
regulatory mechanism as H+ antiport, so that when amino acid flux is high, which 
increases intracellular pH through coupled H+ efflux, the uncoupled H+ transport acts as a 
buffer (24).  The uncoupled H+ transport then serves to drive amino acid transport 
through coupled H+ movement when the amino acid is readily available or initiate efflux 
when concentrations of amino acid are reduced (24). 
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This was, however, a much disputed mechanistic view.  Schneider et al. observed 
in addition to the findings above, that SNAT3 expressed in Xenopus oocytes exhibited a 
substrate-independent cation conductance active at alkaline pH (124).  When Na+ binds, 
this cation conductance is effectively inhibited.  Additionally, with glutamine available as 
a substrate, SNAT3 exhibits Na+/H+ exchange activity; this was originally described 
above as a blunting of intracellular pH, but is now shown to be due to a Na+/H+ 
exchange-related mechanism.  In sum, Schneider et al. found that this uncoupled Na+/H+ 
exchange activity results in significantly increased Na+ influx when glutamine is the 
substrate (124).      
 SNAT3 expression varies among different organs.  It has been originally 
localized in brain astrocytes but not neurons, and is also expressed in adipose tissue, 
heart, kidney, liver and muscle (15, 16, 25, 46, 141).  A recent paper by Sundberg et al. 
describes the tissue mapping of SLC38 family in various species and performed a 
complete quantitative real-time RT-PCR analysis in rat.  Their work revealed that SLC38 
family members are in fact ancient transporters, with expression in mammals, C.elegans, 
D. melanogaster and A. thaliana (134).  
In the brain, astrocytes play a role in the glutamate-glutamine cycle, producing 
glutamate and γ-aminobutyric acid (GABA) from glutamine in the presence of glutamine 
synthetase.  The glutamine produced is then shuttled into neurons where it is converted to 
glutamate and used for neurotransmission.  SNAT3 has been localized to astrocyte 
processes surrounding glutamatergic, GABAergic and glycinergic synapses throughout 
the CNS, and it is suggested that SNAT3 plays a role in recycling of neurotransmitters 
during synaptic transmission in these areas (15, 25).  In mouse primary astrocytes 
cultures, both Na+-independent and Na+-dependent amino acid transport systems have 
been identified (100), with SNAT3-like activity being the most pronounced.    
The liver is crucial in detoxifying ammonia from the portal blood(53).  In the liver 
acinus, SNAT3 appears to be the likely candidate for periportal uptake of glutamine.  
SNAT3 expressed on periportal hepatocytes participates in glutamine influx and in the 
presence of glutaminase, convert it to glutamate and NH4+ which enters the urea cycle 
and is excreted as urea.  Meanwhile, glutamate is exported from the periportal site and 
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metabolized in the perivenous hepatocyte by glutamine synthetase where ultimately 
glutamine is synthesized and possibly exported via SNAT3 (25, 141).   
 Increases in SNAT3 activity in the kidney have been observed during metabolic 
acidosis.  This is primarily due to increased ammoniagenesis associated with increased 
glutamine transport via SNAT3 on the basolateral aspect of the proximal tubule cell.  
Increases in SNAT3 gene expression have been observed during metabolic acidosis using 
microarray analysis (102).  Since plasma glutamine levels increase substantially during 
metabolic acidosis and are thus redirected from the splanchnic pool to the kidney, it has 
been proposed that SNAT3 could be the transport mechanism involved in glutamine 
influx necessary for ammoniagenesis.  SNAT3 has been detected in the kidney (25), and 
has been shown in many studies to increase on both mRNA and protein level during 
acidosis (68, 91, 102, 127).   
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ABSTRACT 
 
Kidneys produce ammonium to buffer and excrete acids through metabolism of 
glutamine.  Expression of the glutamine transporter Slc38a3 (SNAT3) increases in kidney 
during metabolic acidosis (MA) suggesting a role during ammoniagenesis. Potassium 
depletion and high dietary protein intake are known to elevate renal ammonium 
excretion.  Here, we examined SNAT3, phosphate-dependent glutaminase (PDG), and 
phosphoenolpyruvate carboxykinase (PEPCK) regulation during a control (0.36%) or low 
K+ (0.02%) diet for 7 or 14 days; or a control (20%) or high protein (50%) diet for 7 
days.  MA was induced in control and low K+ groups by addition of NH4Cl.  Urinary 
ammonium excretion increased during MA, K+ restriction alone after 14 days, and during 
high protein intake.  SNAT3, PDG and PEPCK mRNA abundance was elevated in MA 
and 14 day K+ restriction but not during high protein intake.  SNAT3 protein abundance 
was enhanced during MA (both control and low K+) , 14 day low K+ treatment alone, and 
during high protein intake. Seven day dietary K+ depletion alone had no effect.  
Immunohistochemistry showed SNAT3 staining in earlier parts of the proximal tubule 
during 14 day K+ restriction with and without NH4Cl treatment and during high protein 
intake.  In sum, SNAT3, PDG and PEPCK mRNA expression was congruent with urinary 
ammonium excretion during MA. Chronic dietary K+ restriction, high protein intake and 
MA enhance ammoniagenesis, an effect that may involve enhanced SNAT3 mRNA and 
protein expression.  Our data suggest that SNAT3 plays an important role as the 
glutamine uptake mechanism in ammoniagenesis under these conditions. 
 
Keywords: glutamine transporters, renal ammoniagenesis, SNAT3, PDG, PEPCK
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INTRODUCTION 
 
The production of nonvolatile acids in the body, occurring during various disease 
states or alterations in dietary intake, can affect physiological pH manifesting as 
metabolic acidosis.  Nonvolatile acids cannot be removed from the body via the lungs; 
therefore another regulatory mechanism must be in place to reestablish homeostasis.  The 
kidney is responsible for regulating acid-base homeostasis through the synthesis and 
excretion of ammonium (NH4+) in the urine and the regeneration of bicarbonate.  During 
metabolic acidosis, ammonium is produced in the proximal tubule cell by way of 
metabolism of glutamine to glutamate.  Phosphate-dependent glutaminase (PDG) 
catalyzes this reaction in the mitochondria, converting glutamine to glutamate, and 
liberating one molecule of ammonium.  Glutamate is then further metabolized either 
through transamination or via glutamate dehydrogenase to yield α-ketoglutarate (11, 27).  
This metabolic substrate can be shuttled into the tricarboxylic acid cycle or the 
gluconeogenic pathway whereby phosphoenolpyruvate carboxykinase (PEPCK), a key 
enzyme of gluconeogenesis, converts α-ketoglutarate to glucose and two bicarbonate 
molecules  (11, 27).  Thus, PDG and PEPCK are important regulators of ammoniagenesis 
during metabolic acidosis (2, 12, 14).  The bicarbonate molecules generated from these 
processes help to partially alleviate acidosis after release into the blood, while the 
ammonium is excreted into the urine, ultimately restoring systemic pH.   
Dietary potassium (K+) restriction and high protein intake affect acid-base 
homeostasis.  Studies in both animals and humans have observed enhanced renal 
ammoniagenesis, ammonium and acid excretion, and subsequently development of a mild 
alkalosis-like state during dietary K+ depletion (18, 24, 34, 42, 43).  In isolated mouse 
and rat renal proximal tubules, K+ restriction stimulates gluconeogenesis and ammonium 
production (26, 28).  Moreover, high dietary protein intake causes increased net renal 
acid and ammonium excretion, suggesting that metabolism of sulfur-containing amino 
acids elicits the observed effects on acid-base handling (33, 49).  These alterations in 
acid–base homeostasis were also observed in other studies using in vivo microperfusion 
techniques; a diet containing 50% casein resulted in increased net renal acid and 
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ammonium excretion, due in part to enhanced Na+/H+ exchanger, H+-ATPase, and 
endothelin-1 activities (22).   
SNAT3, formerly named SN1, (Slc38a3), belongs to the SLC38 family of 
sodium-coupled neutral amino acid transporters, comprised of both system A and N 
transport systems (23).  This transport system is purported to function in the presence of 
sodium with proton countertransport, with the main driving force for glutamine transport 
being both the Na+ and the glutamine gradient (7, 8).  SNAT3 is highly expressed in the 
liver and brain astrocytes, with modest expression in the kidney, heart and muscle (8, 23).  
Its expression is enhanced on the mRNA and protein level in the kidney during metabolic 
acidosis induced by addition of NH4Cl to the drinking water (20, 21, 25, 29, 37).  We and 
others have previously localized SNAT3 to the basolateral portion of the late proximal 
tubule S3 segment, with expression expanding to the S1 and S2 segments during acidosis.  
Its preference for glutamine and regulation during metabolic acidosis suggest a pivotal 
role in providing substrate for renal ammoniagenesis (21, 25, 37).  Using microarray gene 
expression profiling, we have shown that SNAT3, PDG and PEPCK gene expression are 
concomitantly upregulated in mouse kidney after generating an acid load with NH4Cl 
(29).   
Based on the data described above, we hypothesized that dietary K+ restriction 
and high protein dietary intake could regulate SNAT3, ultimately providing further 
evidence for a role in ammoniagenesis.   
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MATERIAL AND METHODS 
 
Animal experiments and metabolic cage studies 
Twelve week old male NMRI mice (Charles River Laboratories, Sulzfeld, 
Germany) were housed in light-cycled and climate controlled rooms. Experimental 
dietary treatment consisted of placing mice on a control (0.36%) or low K+ (0.02%) diet 
for 7 or 14 days.  The animals were subdivided into either NH4Cl or low K+/NH4Cl 
treated groups (n=8 animals per group); 0.28M NH4Cl and 2% sucrose were added to the 
drinking water for the final 2 days of dietary treatment (3, 39).  Likewise, control and low 
K+ groups were given 2% sucrose in the drinking water.  In a separate series, animals 
were given either a control (20 %) or high (50 %) protein diet for 7 days (n = 8 animals 
per group), where casein was the primary constituent of the high protein diet.  All diets 
were obtained from Kliba (Kaiseraugst, Switzerland).  For all groups, during the final 3 
days of experimental dietary treatment, animals were housed in metabolic cages where 
intake and output were monitored. Urine was collected under mineral oil for the final two 
consecutive 24 h intervals, and urinary pH was measured immediately using a pH 
microelectrode (691 pH meter, Metroholm).  Urinary NH3/NH4+ and creatinine were 
assessed using the Berthelot and Jaffe methods, respectively (6, 36). Mice were 
anesthetized by intraperitoneal injection of ketamine and xylazine, and mixed arterial-
venous blood was collected from the abdominal aorta into heparinized tubes and 
immediately analyzed with a Radiometer ABL 505 blood gas analyzer (Radiometer; 
Copenhagen, Denmark).  Mice were not perfused prior to harvesting kidneys. Since 
SNAT3 is not expressed in whole blood, nor is there evidence that erythrocytes express 
PDG or PEPCK, kidneys were not perfused prior to harvesting them (40).  While there 
are some data suggesting white blood cells exhibit PDG activity, the likelihood of 
contamination by these cells and subsequent false-positive results in our study is minimal 
due to exsanguination resulting during blood collections (9, 10, 31). Kidneys were 
immediately flash-frozen under liquid nitrogen and placed at -80ºC until further 
processing.  All animal experiments were conducted according to Swiss animal welfare 
laws and approved by the Swiss local Animal authority, Zurich, Switzerland.   
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Immunohistochemistry 
For immunohistochemical studies on kidney slices, mice were perfused through the left 
ventricle with phosphate-buffered saline (PBS) followed by a paraformaldehyde-
cacodylate fixative containing a mixture of three buffers: 1) a sodium-cacodylate-Sucrose 
buffer (100 mM sodium-cacodylate, 100 mM sucrose); 2) a sodium-cacodylate-HAES 
fixative containing (60% of final volume of buffer 1, 40% HAES-10%, 3.24 mM MgCl2 x 
6 H2O, 4.36 mM picric acid) and a 3) 25% paraformaldehyde solution (final 
concentration 3%), pH 7.4).  Kidneys were flushed with PBS, removed, cut into slices, 
washed three times with PBS, and frozen in liquid propane cooled with liquid nitrogen.  
The immunostaining procedure was carried out as previously described (39).  Briefly, 5 
µm cryosections were incubated with 0.5% SDS for 5 min, washed three times with PBS, 
and incubated with PBS containing 1% BSA for 15 min before application of the primary 
antibodies.  The primary antibodies (rabbit anti-SNAT3 affinity purified 1:200 (25), goat 
anti 4F2hc 1:400, Santa Cruz Biotechnology, CA, USA) were diluted in PBS and applied 
either for 75 min at RT or overnight at 4°C.  Sections were washed twice with PBS + 
2.7% NaCl for 5 min, once with PBS, and incubated for 1 h at RT with their respective 
secondary antibodies (donkey anti-rabbit Alexa 594 and donkey anti-goat Alexa 488 
diluted 1:1000, Invitrogen, Basel, Switzerland).  Sections were then washed twice with 
PBS + 2.7% NaCl and once with PBS before mounting with Dako Glycergel Mounting 
Media (Dako North America Inc., Carpenteria, CA, USA).  All sections were viewed 
using a confocal microscope (Leica CLSM). Pictures were processed (overlaid) using 
Adobe Photoshop software. 
 
Quantitative Real-time RT-PCR 
Total RNA was extracted from 30 mg of previously frozen, non-perfused kidney 
tissue.  Kidneys were homogenized using a Rotor-stator homogenizer, and RNA 
immediately extracted using Qiagen RNeasy Mini Kit (Qiagen; Hilden, Germany) 
following the manufacturer’s instructions.  DNAse digestion was performed using the 
RNase-free DNAase Set (Qiagen; Hilden, Germany).  Total RNA extractions were 
analyzed for quality, purity and concentration using the NanoDrop ND-1000 
spectrophotometer (Wilmington, DE, USA).  RNA samples were diluted to a final 
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concentration of 100 ng/μl, and cDNA was prepared using the TaqMan Reverse 
Transcriptase Reagent Kit containing 10X RT buffer, MgCl2, random hexamers, dNTPs, 
RNase inhibitors and Multiscribe reverse transcription enzyme (Applied 
Biosystems/Roche; Forster City, CA, USA).  Reverse transcription was performed with 
the Biometra TGradient thermocycler (Goettingen, Germany), with thermocycling 
conditions set at 25ºC for 10 min, 48ºC for 30 min, and 95ºC for 5 min.  Relative mRNA 
expression was determined using quantitative Real-Time RT-PCR using the Applied 
Biosystems 7500 Fast Real-Time PCR system.  Thermocycling conditions consisted of: 
50ºC (2 min), 95ºC (10 min), 95ºC (15 sec; 40 cycles) and 60ºC (1 min).  Forward and 
reverse primer and probe concentrations were 25 µM and 5 µM, respectively.  TaqMan 
Universal PCR master mix 2X (Applied Biosystems/Roche) was used as the Taq 
polymerase.  Primers and probes for SNAT3, phosphate-dependent glutaminase (PDG), 
cytosolic phosphoenolpyruvate carboxykinase (PEPCK) and Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) were generated using Primer Express software from 
Applied Biosystems and synthesized at Microsynth (Balgach, Switzerland) as described 
previously (29).  Probes were generated with the reporter dye FAM at the 5’ end and 
TAMRA at the 3’ end.  Reactions were run in a 96 well plate with each sample run in 
triplicate including a negative control (without Multiscribe reverse transcription enzyme).  
The cycle threshold (Ct) values obtained were ultimately compared to Ct values of the 
endogenous gene HPRT.  Relative mRNA expression ratios were calculated as: R = 
2[Ct(HPRT/β-actin)-Ct(gene of interest)].   
 
Immunoblotting 
Total membrane and cytosolic protein preparations from whole, non-perfused 
kidneys were prepared using a K-HEPES buffer composed of 200 mM mannitol, 80 mM 
HEPES, 41 mM KOH along with the protease inhibitors, PMSF, K-EDTA and leupeptin 
(pH 7.5).  Kidneys were sonicated with 200 µl of K-HEPES buffer on ice using a tip 
sonicator and subsequently centrifuged for 20 min at 2000 rpm at 4ºC.  The supernatant 
was aspirated and placed in an ultracentrifuge (Sorvall, Thermo Fischer Scientific) for 1 h 
at 41,000 rpm at 4ºC.  The supernatant, containing cytosolic proteins, was removed while 
the pellet (membrane proteins) was resuspended in K-HEPES buffer and sonicated 
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briefly to evenly distribute proteins. Protein concentration was measured using the 
BioRad Dc Protein assay (Bio-Rad; Hercules, CA, USA).  75 μg of total membrane 
proteins or 50 μg of cytosolic fraction were mixed with Laemmli sample buffer and 
samples were loaded onto a 10% polyacrylamide gel and SDS-PAGE was performed.  
Proteins were transferred to PVDF membranes (polyvinylidene difluoride membranes; 
Immobilon-P, Millipore, Bedford MA, USA).  Membranes were blocked with Tris-
buffered saline/ 0.1% Tween and 5% non-fat dry milk for 1 h.  Primary antibodies were 
subsequently applied, either for 2 h RT or overnight at 4ºC.  The primary antibodies used 
were: phosphate-dependent glutaminase (PDG), which recognizes both the rat (KGA) 
and human (GAC) kidney-type  isoforms of PDG forming the mature PDG protein (66 
and 68 kDa; a kind gift from N. Curthoys, Colorado State University, USA; diluted 
1:500) (13); anti-PEPCK polyclonal antibody (63 kDa; Cayman Chemical, Ann Arbor, 
MI, USA; diluted 1:1,000), and mouse monoclonal antibody against β-actin (42 kDa; 
Sigma, St. Louis, MO, USA; diluted 1:5,000).  The anti-Slc38a3 antibody was generated 
by immunizing rabbits with a KLH-linked C-terminal peptide for the mouse Slc38a3 
sequence: MEAPLQTEMVEPVPNGKHSEGLLPVI-C (Pineda Antibody Service, 
Berlin, Germany).  The antibody recognized one major band of approximately 55 kDa 
which was completely blocked by preincubation of the serum with the immunizing 
peptide.  Furthermore, this band was not detected in mutant mice lacking the SNAT3 
(Slc38a3) transporter (unpublished observations, S.M. Busque, C.A. Wagner; diluted 
1:10,000). The secondary antibodies used were donkey anti-rabbit horseradish peroxidase 
conjugated diluted 1:12,000, anti-rabbit alkaline phosphatase conjugated diluted 1:5,000, 
and anti-mouse IgG alkaline phosphatase conjugated diluted 1:5,000.  Following a series 
of washing steps and blocking, membranes were treated with alkaline phosphatase or 
horseradish peroxidase conjugated developing solution and exposed to the Diana III 
chemiluminescence detection system (Raytest).  Specific bands on PVDF membranes 
were later quantified using AIDA Image analyzer version 3.44.  Membranes were 
stripped and reprobed for anti-β-actin and subsequent analysis of the protein of interest 
was determined relative to β-actin quantification and reported as relative protein 
abundance (ratio of β-actin/protein of interest).  
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Statistical analyses were performed using unpaired Student’s t-test, and results 
with p < 0.05 were considered statistically significant.  Data are presented as means ± 
SEM.    
 
 32
RESULTS 
 
Dietary potassium restriction increases ammonium excretion and SNAT3 expression 
To corroborate the effects of the experimental diets in both NH4Cl treated control 
and low K+ groups, arterial blood gases, plasma electrolytes, and urinary NH4+ and 
creatinine were evaluated (table 1 and figure 1, respectively).  Blood Cl- was markedly 
elevated in all NH4Cl treated groups (control and low K+ both 7 or 14 days), consistent 
with hyperchloremic metabolic acidosis. Blood pH and HCO3- levels were notably lower 
in the NH4Cl treated and 14 day low K+/NH4Cl treated groups, however not during 7 day 
low K+/NH4Cl treatment.  As expected, blood K+ levels were found to be appreciably 
lower in the 14 days K+ restricted groups (low K+ alone and NH4Cl treated), while 7 day 
restriction alone showed only a trend towards reduced blood K+ levels.  Urinary pH was 
significantly decreased in all NH4Cl treated groups, but only slightly decreased after 14 
day low K+/NH4Cl treatment, bearing no significance.  Low K+ treatment alone (7 or 14 
days) did not alter urinary pH.  24 hr urinary NH4+ excretion was augmented in all NH4Cl 
treated groups as well as during 14 day low K+ treatment alone.  Dietary K+ restriction 
after 14 days, compounded by NH4Cl treatment for 2 days, caused massive ammoniuria. 
Kidneys from all groups: control, NH4Cl treated, and 7 and 14 day low K+ diet 
with and without NH4Cl treatment, were assessed for mRNA expression of SNAT3, PDG 
and PEPCK using quantitative Real-time RT-PCR.  SNAT3 mRNA abundance was 
found to be markedly enhanced in all NH4Cl treated groups, with a significant further 
increase after 14 days of combined low K+/NH4Cl treatment (figure 2A).  In parallel to 
SNAT3 mRNA expression, both PDG and PEPCK mRNA were found to be similarly 
regulated in that all NH4Cl treated groups showed significantly increased expression of 
each enzyme (figure 2B, C), similar to previous findings (14).  Dietary K+-restriction for 
7 days did not increase SNAT3, PDG, or PEPCK mRNA abundance appreciably in 
comparison to control mice, while 14 days of K+ restriction resulted in a significant 
decrease in PDG expression, with SNAT3 and PEPCK remaining unchanged.  In sum, 
mRNA expression of SNAT3, PDG and PEPCK paralleled urinary NH4 excretion in 
these animals, suggesting that SNAT3 may play a role in providing glutamine for 
ammoniagenesis under these conditions. 
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To substantiate the results of our mRNA analyses using quantitative Real-time 
RT-PCR, we performed immunoblotting with both total membrane (for SNAT3) and 
cytosolic proteins (for PDG, PEPCK) from homogenized kidneys.  Immunoblots were 
normalized to controls relative to β-actin protein quantification.  We observed a 
significant increase in SNAT3 protein abundance in NH4Cl (2 days), low dietary K+ (14 
days) treatment alone, and after 14 day low K+/NH4Cl treatment (figure 3A-F).  
Alternatively, enhanced PDG protein abundance was only observed after 14 day low K+ 
treatment, (both low K+ alone and low K+/NH4Cl treated; figure 4A-F) while PEPCK 
protein abundance was augmented only during NH4Cl treatment in both control and 14 
day low K+ treatment (figure 5A-F).  These data suggest that key enzymes involved in 
renal ammoniagenesis and gluconeogenesis are indeed regulated after K+ restriction and 
acid loading.  To determine whether it was solely K+ restriction or the combination of K+ 
restriction in addition to acid loading, we immunoblotted kidneys from 14 day treated 
mice with and without NH4Cl treatment.  We found significantly more SNAT3 and 
PEPCK protein abundance in K+ restricted mice after administering an acid load relative 
to non-acid loaded mice (figure 6A-F).  Therefore, in agreement with both SNAT3 
mRNA expression levels and urinary ammonium excretion, compounding K+ depletion 
and NH4Cl treatment significantly increases SNAT3 and PEPCK protein in these mice.   
 
  High dietary protein intake stimulates ammonium excretion and SNAT3 
abundance 
High dietary protein intake has been shown to provide a substantial acid load to 
the body.  Mice were assigned to a control (20 %) or high (50 %) dietary protein (purely 
casein) diet for 7 days.  Arterial blood gases and urinary ammonium were measured to 
determine the effectiveness of the diet.  Blood parameters were unremarkable and similar 
between the normal and high protein groups (table 2).  The only disparities in renal acid-
base handling were observed in the urine.  Urinary pH was significantly decreased in the 
high protein group compared to controls (pH = 6.90 ± 0.20 vs 7.49 ± 0.01, respectively), 
suggesting excretion of acid equivalents by the kidneys.  Moreover, urine volume, 24 hr 
NH4 excretion and NH4/creatinine ratio were substantially increased in comparison to 
controls (table 2, figure 7), in agreement with previous observations (22). 
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Relative mRNA expression was determined in both the normal and high protein 
groups.  SNAT3, PDG and PEPCK mRNA did not significantly change in comparison to 
the normal protein intake group (figure 8A-C).  In fact, the only discernable difference 
between groups was observed on the protein level.  SNAT3 protein abundance was 
significantly upregulated in the high protein group, in accordance with a trend towards 
higher protein abundances of PDG and PEPCK, however no statistical significance was 
observed (figure 9A-F).  Thus, high dietary protein intake resulted in reduced urinary pH 
and elevated urinary ammonium excretion paralleled by increased SNAT3 protein 
abundance. 
 
SNAT3 localization spreads to the convoluted segments of the proximal tubule after 
K+ restriction and high protein intake 
We and others have previously shown that SNAT3 is localized to the basolateral 
membrane of late proximal tubule segments under basal conditions and that its expression 
spreads to earlier parts of the proximal tubule during NH4Cl-induced acidosis (25, 29, 
37).  Here, we tested whether 14 day K+ restriction, 14 day K+ restriction with additional 
NH4Cl-treatment, or a high protein diet had a similar effect by using 
immunohistochemistry.  Early proximal tubules were identified by staining with 
antibodies against the 4F2hc (CD98) subunit of heteromeric amino acid transporters (5, 
25).  Under basal conditions, SNAT3 related staining was observed mostly in the late 
proximal tubule (straight or S3 segment).  In kidneys from animals with 14 day K+ 
restriction, 14 day K+ restriction and NH4Cl, or high protein dietary treatment, a distinct 
and more intensive SNAT3 related signal was observed in the S2 segment with some 
additional staining of the S1 segment (figure 10).  Thus, SNAT3 expression expanded to 
earlier segments of the proximal tubule in response to treatments that stimulate renal 
proximal tubular ammoniagenesis and ammonium excretion. 
 35
DISCUSSION 
 
The aim of this study was to test for regulation of the renal glutamine transporter 
SNAT3 during conditions associated with increased ammoniagenesis.  We also measured 
induction of two major enzymes involved in renal ammoniagenesis, namely, 
mitochondrial phosphate-dependent glutaminase (PDG) and cytosolic 
phosphoenolpyruvate carboxykinase (PEPCK).  Our data demonstrate that K+ restriction, 
high dietary protein intake, and metabolic acidosis induced by NH4Cl feeding, increased 
urinary ammonium excretion, paralleled by a concomitant elevation in abundance of the 
glutamine transporter SNAT3.   
We used three distinct dietary animal models to stimulate renal ammoniagenesis 
and ammonium excretion; classic NH4Cl-loading which, after metabolism in the liver, 
produces a metabolic acid load; dietary K+ restriction, which is thought to induce an 
intracellular acidosis due to the shift of intracellular potassium in exchange for 
extracellular protons (1); and a high protein diet rich in sulfur-containing amino acids 
which also constitutes as a metabolic acid load.  In all three animal models, renal 
ammonium excretion was stimulated and SNAT3 protein expression increased, however, 
with distinct differences. 
NH4Cl-loading has been previously reported to increase SNAT3 mRNA and 
protein abundance (21, 25, 29, 37).  During NH4Cl-induced metabolic acidosis, SNAT3 
expression spreads from the late to the early proximal tubule (25, 29, 37).  Similarly, we 
found increased SNAT3 related staining in the earlier portions of the proximal tubule (S2 
and weakly in S1) during 14 day K+ depletion, 14 day K+ depletion with NH4Cl 
treatment, and during high protein intake. Increased SNAT3 expression is paralleled by 
enhanced mRNA expression of two key ammoniagenic enzymes, PDG and PEPCK, as 
previously reported (11, 17, 29).  Protein abundance of PEPCK was also increased, 
whereas enhancement of PDG protein is known to occur with slightly more delay (11).  
Of note, we did not directly measure transport or enzyme activity, and therefore, 
additional conclusions regarding regulation on the functional level cannot be inferred 
from our data. The effect of K+ restriction on renal acid-base transport and 
ammoniagenesis has been well documented in animals and humans (15, 16, 19, 30, 41, 
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43, 44).  In the proximal tubule, enhanced expression and activity of the apical Na+/H+ 
exchanger, NHE3, contributes to enhanced NH4+ excretion into the lumen (38).  
Moreover, K+ restriction increases H+-ATPase and H+/K+-ATPase transport activities in 
the distal nephron and reduces expression of the collecting duct bicarbonate exchanger, 
pendrin, promoting the development of metabolic alkalosis (4, 35, 45).  Importantly, 
renal ammoniagenesis in the proximal tubule is stimulated during K+ depletion (15, 16, 
30, 34, 44).  In our experiments, we observed hypokalemia in both 14 day K+ restricted 
groups, with and without NH4Cl treatment. Interestingly, 14 days of low K+ treatment 
alone resulted in a small but significant increase in urinary ammonium excretion, while 
compounding K+ restriction with NH4Cl resulted in excessive ammonium excretion. 
Despite having observed the development of mild hypokalemia in 7 day dietary K+ 
restricted mice, there was no significant increase in urinary ammonium excretion.  In 
addition, mRNA expression of SNAT3, PDG and PEPCK did not considerably change 
after 7 days of K+ restriction in comparison to controls, while the 14 day K+ restricted 
group showed only decreased PDG mRNA expression.  No differences in SNAT3 or 
PEPCK mRNA levels could be detected in the 14 day low K+ treatment group alone 
despite a slight increase in urinary ammonium excretion.  Whether this minor increase in 
ammonium excretion is due to ammoniagenesis per se or enhanced collecting duct 
ammonium excretion remains to be examined, however it has been shown that 
hypokalemia can enhance ammonium uptake in collecting duct cells via Na+,K+-ATPases 
(46).   
Acid loading mice with NH4Cl in both 7 and 14 day low K+ treated mice showed 
massive increases in ammonium excretion.  In contrast to mRNA expression, 14 day low 
K+ treatment alone showed enhanced SNAT3 and PDG, but not PEPCK protein 
abundance.  NH4Cl-loading these mice showed increased protein levels of all three 
proteins; SNAT3, PDG and PEPCK in congruence with mRNA expression.  These data 
suggest that regulation of ammonium excretion differs during hypokalemia stimulated 
ammoniagenesis and NH4Cl-induced metabolic acidosis.  This interpretation is supported 
by the fact that urinary ammonium excretion, SNAT3, PDG, and PEPCK mRNA, and 
protein increased even more when dietary K+ restriction and NH4Cl-loading were 
combined, suggesting an additive effect of the two treatments. 
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Increased protein intake is associated with higher consumption of sulfur-
containing amino acids, generating a physiological acid load.  High protein intake 
decreases urinary pH and increases net acid excretion (22, 32, 33, 47, 49).  Additionally, 
increases in luminal Na+/H+ exchange activity in the proximal tubule as a result of 
enhanced endothelin production are associated with high dietary protein consumption, 
which may contribute to higher renal ammonium excretion (48).  In agreement, we found 
a significant decrease in urinary pH in high protein treated animals in comparison to 
controls.  Further, these animals had substantially elevated 24 hr urinary ammonium 
excretion and NH4+/creatinine ratios suggesting enhanced ammoniagenesis.  
Interestingly, despite higher urinary ammonium excretion, no differences in mRNA 
expression of SNAT3, PEPCK, and PDG could be detected.  Moreover, only SNAT3 
protein abundance was significantly enhanced, whereas the mildly elevated protein 
abundance of PDG and PEPCK did not reach significance.  Thus, as in the case of dietary 
K+ restriction, regulatory mechanisms appear to differ between NH4Cl-induced metabolic 
acidosis and dietary protein loading. 
 The mechanism by which SNAT3 expression is regulated in response to these 
distinct stimuli may vary.  In the case of NH4Cl-loading, Solbu et al. suggested that 
binding of an unidentified protein to SNAT3 mRNA via a pH-responsive AU-rich 
domain in the 3’UTR  may lead to its stabilization and thereby contribute to elevated 
SNAT3 mRNA expression (37).  A similar mechanism has been identified for PDG and 
PEPCK (11, 17).  It remains to be investigated if such mechanisms also contribute to 
SNAT3 regulation during K+ restriction or dietary protein loading.  Several hormones 
have been implicated in stimulating ammoniagenesis, such as glucocorticoids, 
angiotensin II, insulin and aldosterone (11).  The increased expression of SNAT3 during 
NH4Cl-induced metabolic acidosis may, at least in part, be mediated by cortisol; cortisol 
could potentially stimulate SNAT3 expression, independent of metabolic acidosis (20). 
In sum, we have demonstrated that diets and conditions that stimulate renal 
ammoniagenesis and urinary ammonium excretion lead to higher expression of the 
SNAT3 glutamine transporter.  This positive correlation and the localization of SNAT3 
to the basolateral membrane of the late proximal tubule strongly suggest that SNAT3 
plays a pivotal role in supplying the proximal tubule with glutamine for ammoniagenesis.  
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Notably, not all conditions that increased SNAT3 protein abundance resulted in a 
concomitant increase in mRNA expression, suggesting that variations in underlying 
regulatory mechanisms may be responsible.  Further studies are needed in order to 
address these points in more detail.  SNAT3 expression and activity may be rate-limiting 
and key for fueling ammoniagenesis and renal acid excretion. 
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FIGURE LEGENDS 
Table 1 
Summary of results from arterial blood gas and urine analyses for mice treated for 7 or 14 
days with a low K+ diet with or without NH4Cl supplementation in the drinking water for 
the final 2 days.  Control animals received standard rodent chow (n = 8 mice per group). 
*p ≤ 0.05, **,§§p ≤ 0.01, ***,§§§p≤ 0.001.  Comparisons between control and treatment 
groups are designated by *, while comparisons between K+ restricted groups are 
designated by §. 
 
Table 2 
Summary of results from arterial blood gas and urine analyses for mice receiving 20 % or 
50 % protein diet for 7 days (n = 8 animals). *p ≤ 0.05, **p ≤ 0.01, ***p≤ 0.001 between 
control and treatment groups. 
 
Figure 1 
Urinary NH4 excretion is elevated in K+ restricted animals with and without NH4Cl 
treatment.  Mice were placed on either a control or low K+ diet for 7 or 14 days, further 
subdivided, and treated with NH4Cl in the drinking water for the final 2 days of dietary 
treatment.  Mice were subsequently placed in metabolic cages for 24 hr urine collections.  
Urinary NH4+ excretion was elevated in all groups receiving NH4Cl.  Mice on 7 day K+ 
restriction had normal ammonium excretion, whereas mice on 14 day K+-restriction had 
notably higher ammonium excretion. *p ≤ 0.05, **p ≤ 0.01, ***p≤ 0.001.   
  
Figure 2 
mRNA expression of renal SNAT3, PDG, and PEPCK is enhanced in potassium 
restricted mice and after NH4Cl supplementation.  mRNA abundance of the SNAT3 
glutamine transporter, (A), phosphate-dependent glutaminase (PDG), (B), and 
phosphoenolpyruvate carboxykinase (PEPCK), (C) was determined by quantitative real-
time RT-PCR in total kidneys.  Significant increases in SNAT3, PDG, and PEPCK 
mRNA was observed in all NH4Cl-treated groups (both 7 and 14 day treatment).  
Relative mRNA expression was normalized to HPRT mRNA expression.  *p ≤ 0.05, **p 
≤ 0.01, ***p≤ 0.001.  
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Figure 3 
 SNAT3 protein abundance is enhanced during K+ restriction and NH4Cl loading. 
Total membranes were extracted from whole, non-perfused kidneys from mice on K+ 
restriction with or without NH4Cl supplementation.  Membranes were probed with 
antibodies against SNAT3 and reprobed after stripping for β-actin to control for equal 
loading.  Original blots are depicted with bar graphs summarizing normalized data.  (A, 
B) Enhanced SNAT3 protein abundance was observed after 2 days of NH4Cl treatment.  
(C,D) SNAT3 protein abundance is upregulated after 14 days of K+ restriction.  (E,F) 
Combined K+ restriction for 14 days and 2 days of NH4Cl treatment markedly enhanced 
SNAT3 protein abundance. **p ≤ 0.01 between control and treatment groups. 
 
Figure 4 
PDG protein levels are enhanced during K+ restriction. Cytosolic proteins were 
extracted from whole, non-perfused kidney samples from mice on a low K+ diet with or 
without NH4Cl supplementation.  Membranes were probed with antibodies against the 
mitochondrial phosphate-dependent glutaminase and reprobed after stripping for β-actin 
to control for equal loading.  Original blots are depicted along with bar graphs 
summarizing normalized data.  (A, B) NH4Cl treatment for 2 days did not alter PDG 
protein abundance.  (C,D) After 14 days of dietary K+ restriction, PDG abundance is 
significantly increased.  (E,F) Combined K+ restriction for 14 days with 2 days of NH4Cl 
treatment also enhanced PDG protein expression.  *p ≤ 0.05, ***p ≤ 0.001 between 
control and treatment groups. 
 
Figure 5 
Phosphoenolpyruvate carboxykinase (PEPCK) protein abundance is augmented only 
by NH4Cl loading but not K+ restriction. The expression of PEPCK was assessed in 
cytosolic protein preparations by immunoblotting, Membranes were probed with 
antibodies against PEPCK and reprobed after stripping for β-actin to control for equal 
loading.  Original blots are depicted along with bar graph summarizing normalized data.  
(A, B) 2 day NH4Cl treatment strongly enhanced PEPCK protein abundance.  (C,D) After 
14 days of dietary K+ restriction, PEPCK abundance was not significantly altered.  (E,F) 
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Combined dietary K+ restriction for 14 days with 2 days of NH4Cl supplementation 
enhanced PEPCK protein expression.  *p ≤ 0.05, **p ≤ 0.01 between control and 
treatment groups. 
 
Figure 6 
NH4Cl loading in 14 day K+ restricted mice showed augmented SNAT3 and PEPCK 
protein abundance.  Plasma membrane and cytosolic proteins were extracted from 
whole, non-perfused kidneys and probed for SNAT3, PDG, PEPCK, and β-actin.  
Original blots and bar graphs summarizing normalized data are shown.  (A,B) SNAT3 
abundance is markedly enhanced after NH4Cl administration.  (B, C) No changes in PDG 
abundance were noted among K+ restricted groups with or without NH4Cl treatment.  
(E,F) Acid-loading K+ restricted mice showed augmented PEPCK protein in comparison 
to non-acid loaded controls.  **p ≤ 0.01, ***p ≤ 0.001 between groups. 
 
Figure 7 
Urinary NH4 excretion was substantially elevated in high protein diet fed animals.  
Mice were given either a normal (20%) or high (50%) protein diet for 7 days.  The final 3 
days of dietary treatment animals were placed in metabolic cages and urine was collected 
every 24 hrs.  Ammonium excretion was significantly elevated in the high protein treated 
group (n = 8 mice per group).  **p ≤ 0.01. 
   
Figure 8 
 SNAT3, PDG, and PEPCK are not regulated on mRNA level during high dietary 
protein intake.  Total kidney homogenates were prepared from mice either on a 20 % or 
50 % protein diet.  mRNA expression of SNAT3, PDG, and PEPCK was assessed by 
quantitative real-time RT-PCR and normalized against HPRT mRNA expression.  No 
significant differences were found between the two groups.  
 
Figure 9 
SNAT3 protein abundance is markedly upregulated during high dietary protein intake. 
Plasma membrane and cytosolic proteins were extracted from whole, non-perfused 
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kidneys and probed for SNAT3, PDG, PEPCK, and β-actin.  Origianl blots and bar 
graphs summarizing normalized data are shown.  (A,B) SNAT3 abundance is increased 
during 50 % protein intake.  (C-F) PDG and PEPCK protein abundance showed mildly, 
but not significantly, elevated expression after 7 days of high protein diet.  ***p ≤ 0.001 
between groups. 
 
Figure 10 
SNAT3 related staining expands to earlier segments of the proximal tubule in response 
to treatments stimulating ammoniagenesis. Kidneys were stained with antibodies against 
the 4F2hc (CD98) amino acid transporter subunit (green) to mark the early convoluted 
proximal tubule (S1 segment) and against SNAT3 (red). The dashed line marks the 
transition from the outer stripe of the outer medulla to the inner stripe of the outer 
medulla. (A) Control conditions, (B) 2 day NH4Cl treatment, (C) 14 day K+ restriction, 
(D) 14 day K+ restriction and 2 day NH4Cl treatment, and (F) high dietary protein (50 %) 
intake. Original magnification 40 x. 
Table 1 
Arterial blood gas and urine analysis 
 7 days 14 days 
Groups Control NH4Cl 
2 days 
Low K+ Low K+ 
NH4Cl 2 days 
Control Low K+ Low K+ 
NH4Cl 2 days 
Blood        
pH 7.28 ± 0.01 7.15 ± 0.03** 7.32 ± 0.03 7.26 ± 0.03   7.28 ± 0.01 7.29 ± 0.01 7.10 ± 0.04**§§§ 
pCO2 40.1 ± 1.2 35.8 ± 1.7 37.9 ± 3.3 35.9 ± 3.6 48.6 ± 1.1 48.8 ± 1.7 54.8 ± 5.7 
HCO3-  (mM) 17.8 ± 0.7 12.6 ± 1.2** 18.1 ± 2.7 16.1 ± 1.3 19.5 ± 0.6 20.2 ± 0.4 13.04 ± 1.2***§§§ 
Na+  (mM) 145.6 ±  0.8 148.4 ± 1.5 145.9 ± 1.5 148.7 ± 0.7** 145.6 ± 0.6 146.0 ± 1.3 148.4 ± 0.8* 
Cl-  (mM) 107.8 ± 0.6 120.9 ± 1.5*** 105.8 ± 2.4 119.7 ± 1.0***§§§ 108.5 ± 0.8 106.7 ± 1.2 117.6 ± 1.3***§§§ 
K+  (mM) 3.9 ± 0.3 4.6 ± 0.9 3.1 ± 0.4 4.3 ± 0.4 3.5 ± 0.1 3.1 ± 0.1* 3.6 ± 0.2§ 
Body wt  (g) 36.2 ± 0.7 36.1 ± 0.6 34.7 ± 0.8 33.8 ± 0.5** 39.2 ± 1.2 36.9 ± 1.0 34.4 ± 1.8* 
        
Urine        
pH 6.59 ± 0.1 5.68 ± 0.1*** 6.81 ± 0.2 5.94 ± 0.2**§§ 6.77 ± 0.1 6.89 ± 0.3 6.31 ± 0.2 
urine vol (µl/g body 
wt/24h) 
46.8 ± 8.0 23.0 ± 7.0* 85.9 ± 24.1 29.6 ± 6.2 47.0 ± 20.2 79.2 ± 22 73.4 ± 27.0 
NH4(mmol)/creatinine 
(mg/dl) 
1.9 ± 0.6 10.3 ± 1.1*** 1.8 ± 0.5 7.9 ± 1.2 1.3 ± 0.2 2.6 ± 0.9 26.0 ± 10.7** 
NH4(mmol)/24h 0.14 ± 0.05 0.46 ± 0.17* 0.11 ± 0.04 0.47 ± 0.12*§§ 0.07 ± 0.01 0.21 ± 0.07* 1.12 ± 0.1*** §§§  
Table 2 
Arterial blood gas and urine analysis 
 
 
Groups 20 % protein 50 % protein 
Blood   
pH 7.30 ± 0.01 7.31 ± 0.02 
pCO2 42.7 ± 3.7 41.1 ± 1.2 
HCO3-  (mM) 20 ± 1.3 19.8 ± 1.04 
Na+  (mM) 148.0 ± 2.0 147.0 ± 1.0 
Cl-  (mM) 111.0 ± 1.1 109.0 ± 1.0 
K+ (mM) 7.01 ± 0.4 6.6 ± 0.3 
Body wt (g) 36.5 ± 2.0 35.3 ± 1.0 
   
Urine   
pH 7.49 ± 0.10 6.90 ± 0.20**  
urine vol (µl/g body 
wt/24h) 
63.2 ± 25.0 190.9 ± 16.1*** 
NH4(mmol)/creatinine 
(mg/dl) 
0.7 ± 0.35 5.1 ± 1.6* 
NH4(mmol)/24h 0.03 ± 0.01 0.37 ± 0.09** 
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V. Dysregulation of the glutamine transporter SNAT3 (Slc38a3) and ammoniagenic 
enzymes in obese, glucose-intolerant mice  
 
V.1 Diabetes mellitus and uric acid nephrolithiasis 
 
The prevalence of diabetes and metabolic syndrome in industrialized countries 
has reached epidemic proportions.  Type II diabetes in particular is a condition associated 
with insulin resistance; the body is incapable of effectively transporting glucose into 
insulin-dependent cells in response to a carbohydrate-containing meal.  Metabolic 
syndrome, on the other hand, is characterized as having a variety of medical disorders 
including hyperlipidemia, hypertension, insulin resistance, and increased abdominal 
adiposity.  The combination of these disorders increases the risk of developing 
cardiovascular disease and diabetes (8, 82).  In recent years, the incidence of 
nephrolithiasis has increased in parallel to that of type II diabetes and metabolic 
syndrome, and it has been suggested that a relationship may exist between these 
metabolic disorders and renal stone formation (89, 129, 137, 139).  A large cross-
sectional analysis comparing three large epidemiological studies over a 44 year period 
found that diabetes appeared to be a significant risk factor for developing uric acid 
nephrolithiasis, and had suggested that insulin resistance could be the effecter (137).  
Uric acid nephrolithiasis (UAN) is highly associated with low urinary pH and urine 
volume, hyper- or normouricosuria, an increased incidence of diabetes or insulin 
resistance (7, 36, 37, 84, 120).  Pharmacological treatment with potassium or sodium 
citrate has been proven to increase urinary pH and inhibit UA stone formation, providing 
further evidence that UAN is linked to low urinary pH (65, 71, 104, 105, 121).  Diabetic 
patients with UAN also have reduced urinary NH4+ excretion which may explain the 
occurrence of low urinary pH values and thus may increase the risk of developing UAN.  
This may indicate a defect in renal ammoniagenesis or excretion, since a low urinary pH 
usually results in enhanced NH4+ excretion in the urine (1, 50, 54, 65, 111, 120).  
Moreover, giving these subjects an acid challenge results in a reduced capacity to acidify 
their urine in comparison to healthy controls (120). 
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V.2 Insulin action in the kidney 
 
In addition to NH3 production, the renal proximal tubule is also an important site 
of insulin action.  At steady state the liver is the predominate gluconeogenic organ, 
however the kidney can supply the body with relatively low levels of de novo glucose, 
which can increase substantially during a prolonged fast, starvation or hepatic injury (40, 
72, 103).  Induction of diabetes in rats in vivo or in renal cortex slices results in increased 
gluconeogenesis, while insulin administration results in a substantial decrease in 
gluconeogenic activity (62, 72, 83, 116).  Furthermore, gluconeogenic enzyme activity 
and stimulation of gluconeogenesis via various precursors is enhanced and has been 
localized to the renal proximal tubule (19, 47, 48, 116, 143). 
Insulin resistance is a condition whereby physiological amounts of insulin are not 
sufficient enough to induce a typical insulin response, such as mobilizing glucose into 
muscle after a meal.  There is evidence suggesting that insulin resistance can reduce renal 
ammoniagenesis, resulting in a lower urine pH and the potent formation of uric acid 
stones (1, 120).  Increases in renal PDG production and glutamine utilization have been 
observed upon insulin administration, suggesting enhanced renal ammoniagenesis (26, 
77).  
Taken the above observations into consideration, our aim was to determine if 
renal SNAT3, PDG and PEPCK are altered using a model of diet-induced-obesity and 
insulin-resistance, which could explain the observed effects on renal ammoniagenesis and 
low urinary pH in patients with type II diabetes.      
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ABSTRACT 
 
Uric acid nephrolithiasis is prevalent among patients with type 2 diabetes and metabolic 
syndrome; it is correlated with an acidic urine and lower urinary ammonium excretion 
and is likely associated with insulin resistance.  Insulin stimulates ammoniagenesis in 
renal cell lines, possibly via increased phosphate-dependent glutaminase (PDG) activity 
and glutamine metabolism. Ammonium excretion is mediated at least in part by the 
proximal tubule Na+/H+-exchanger NHE3 and in the collecting duct involving the Rhesus 
protein Rhcg.  Here we tested, whether obesity and insulin resistance in a diet-induced 
model could contribute to deranged ammonium excretion.  Diet-induced obesity was 
produced and confirmed by pathological intraperitoneal glucose tolerance tests (IPGTT). 
Three groups of mice were compared: control; obese, glucose-intolerant with abnormal 
IPGTT (O-GI); or moderate weight with normal IPGTT mice (non-responders, NR).  
Basal urinary ammonium excretion did not differ among groups.  However, acid loading 
increased urinary ammonium excretion in all groups, but to a lesser extent in the O-GI 
group.  SNAT3 mRNA expression was enhanced in both obese groups.  PDG expression 
was elevated only in acid-loaded O-GI mice, whereas PEPCK was enhanced in both O-
GI and NR groups given NH4Cl.  NHE activity in the brush border membrane of the 
proximal tubule was strongly reduced in the O-GI group whereas Rhcg expression was 
similar.  In sum, obesity and glucose intolerance impairs renal ammonium excretion in 
response to NH4Cl feeding most likely through reduced NHE activity. The stimulation of 
SNAT3 and ammoniagenic enzyme expression may be compensatory but futile.    
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INTRODUCTION 
 
The prevalence of diabetes from a global perspective has reached approximately 
170 million and is expected to rise (86).  In the United States alone, approximately 23.6 
million people have diabetes, while 76 million have metabolic syndrome, a combination 
of disorders including hyperlipidemia, hypertension, insulin resistance and increased 
abdominal adiposity, increasing the risk of developing cardiovascular disease and 
diabetes (4, 51).  Interestingly, the incidence of nephrolithiasis in this population has 
increased in parallel, and it has been suggested that a relationship may exist between 
these metabolic disorders and renal stone formation (56, 76, 79, 81).   A recent cross-
sectional analysis comparing three large epidemiological studies over a 44 year period 
found that diabetes appeared to be a significant risk factor for developing uric acid 
nephrolithiasis (UAN), and had suggested that insulin resistance could be the effecter 
(79).  UAN is highly associated with low urinary pH and urine volume, hyper- or 
normouricosuria, and the increased incidence of diabetes or insulin resistance (3, 19, 20, 
53, 69).  Pharmacological treatment with potassium or sodium citrate has been proven to 
increase urinary pH and inhibit UA stone formation, providing further evidence that 
UAN is linked to low urinary pH (36, 40, 63, 64, 70).  Patients with diabetes and UAN 
not only have low urinary pH values, but also exhibit decreased renal ammonium (NH4+) 
excretion.  The mechanism likely involves defective renal ammoniagenesis or excretion 
since a low urinary pH usually is associated with enhanced NH4+ excretion in the urine 
(1, 27, 30, 36, 66, 69).  Furthermore, functional acid-loading tests in these patients 
resulted in a reduced capacity to acidify their urine in comparison to healthy controls 
(69).   
Renal ammoniagenesis and gluconeogenesis increase substantially in the proximal 
tubule (PT) in response to acute or chronic metabolic acidosis.  This is a direct result of 
the shunting of glutamine from the visceral or splanchnic pool to the kidney, with 
concomitant increases in glutamine extraction from arterial blood (61, 84).  We and 
others have shown that glutamine influx is likely due to the basolateral proximal tubule 
glutamine transporter Slc38a3 (SNAT3), since increased SNAT3 expression has been 
observed during MA (38, 39, 57, 60, 75).  Recent work by our group has also shown 
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enhanced SNAT3 mRNA and protein in response to potassium restriction or a high 
protein diet,, conditions that create an acidosis-like state and stimulate renal 
ammoniagenesis (12, 34, 55, 58, 59, 67, 71, 78, 85).    Glutamine is then transported into 
the mitochondrial matrix of the PT cell and metabolized.  One NH4+ ion is liberated 
through the deamidation of glutamine to glutamate via phosphate-dependent glutaminase 
(PDG), while another NH4+ ion is produced upon conversion of glutamate to α-
ketoglutarate.  In the PT cell cytosol, α-ketoglutarate has two metabolic fates; as a 
substrate in the tricarboxylic acid cycle, or as a precursor of de novo glucose synthesis in 
the presence of phosphoenolpyruvate carboxykinase (PEPCK), resulting in the 
production of two bicarbonate molecules.  Increases in PDG and PEPCK enzyme activity 
during MA have been associated with a concomitant increase in mRNA levels and 
protein abundance and are thus important regulators of ammoniagenesis (11, 13, 16, 18, 
32, 33, 80).  These two enzymes are, however, differentially regulated.  PDG is 
augmented during MA as a result of increased stabilization of its mRNA secondary to the 
binding of ξ-crystallin/NADPH:quinone reductase to a pH responsive AU-rich region in 
the 3’ untranslated region of its mRNA, while increases in PEPCK are mostly the result 
of augmented transcription of the PEPCK gene (16, 28, 29, 44, 45).  
 Once NH4+ is produced in the PT, it is transported into the tubular lumen.  This is 
accomplished either via diffusion as NH3 where it can trap protons, or it can be 
transported as NH4+.  A key protein involved in the luminal transport of NH4+ as well as 
providing protons for bicarbonate reabsorption is the Na+/H+ exchanger, NHE3.  It has 
been localized to the brush borer membrane of the PT and has been shown to increase 
during NH4Cl-induced MA (2, 43, 87).  Reabsorption of NH4+ produced by the PT occurs 
in the medullary thick ascending limb largely by the activation of a luminal Na+/K+/2Cl- 
cotransporter (NKCC2) (5).  After accumulation in the medullary interstitium, NH4+ is 
ultimately excreted in the final urine, via the Rhesus factor Rhcg protein (37).  In 
response to an acid load, Rhcg mutant mice reveal defective urinary NH4+ excretion (9)  
In addition to ammoniagenesis, the renal proximal tubule is also an important 
gluconeogenic site and is responsive to insulin action (11, 25, 26, 68, 83). Induction of 
diabetes in rats in vivo or in renal cortex slices results in increased gluconeogenesis, 
while supplying insulin results in a substantial decrease in gluconeogenic activity (35, 41, 
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52).  Further, insulin can also stimulate NHE3 activity in the proximal tubule (21, 24, 42, 
73).  A recent study has shown that Zucker diabetic fatty rats exhibit reduced urinary 
NH4+ and pH, with a concomitant reduction in renal brush border membrane NHE3 
activity, suggesting that renal NH4+ excretion is reduced in part by a reduction in NHE3 
activity (10).   
Given that both ammoniagenesis and gluconeogenesis are closely linked in the 
renal proximal tubule cell, we hypothesized that a diet-induced, glucose-intolerant state 
could alter renal ammoniagenesis through dysregulation of the glutamine transporter 
SNAT3, renal ammoniagenic and gluconeogenic enzymes, PDG and PEPCK, or transport 
proteins involved in renal NH4+ excretion.  Modifications in the regulation of these 
proteins could ultimately result in perturbations in ammoniagenesis and excretion, and 
could help to explain the pathogenesis of UAN in subjects with diabetes and metabolic 
syndrome.        
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RESULTS 
“Cafeteria-diet” feeding induces obesity and pathological glucose intolerance in mice 
 
After 10 weeks of a high fat, high energy “cafeteria-style diet”, or a standard 
control diet, all mice (n=72) were subjected to intraperitoneal glucose tolerance testing 
(IPGTT).  Distinct differences were observed among the cohort of cafeteria-diet fed mice.  
Weights were taken weekly throughout the experimental dietary treatment; immediately 
before the IPGTT and on the final 2 days in the metabolic cages (supplemental figure 1, 
figure 1 B, and table 1, respectively).  We observed that the cafeteria-fed mice were 
significantly more obese than control mice.  Further, IPGTT revealed two distinct tiers of 
glucose intolerance among the cafeteria-fed mice (figure 1 A) paralleling the weight 
differential.  Approximately half of the cafeteria-fed mice were significantly obese and 
did not reach euglycemia at the end of the IPGTT (obese, glucose-intolerant; O-GI 
group), while the other half of cafeteria-fed mice were moderately obese and clearly less 
glucose intolerant (non-responders; NR group).  A similar phenomenon has been 
described in rats showing that chronic consumption of a high fat, high calorie diet led to a 
weight differential in roughly half of the study population tested, resulting in obesity and 
insulin resistance (46, 47, 49).  Furthermore, these observations were noted without a 
further increase in food intake in these animals, which has been suggested to be 
associated with irreversible changes in body weight and adiposity set-points.  In our 
study, both O-GI and NR mice gained weight rapidly during the last 7 weeks of cafeteria 
diet-feeding, despite reduced food intake in the metabolic cages during the final days of 
the experimental period (table 1).   
 
Abnormal urinary acid excretion in obese, glucose-intolerant mice 
Mice (n = 48) were placed in metabolic cages after one week of recovery from 
IPGTT and maintained on their respective diets.  The O-GI, NR and control groups were 
subdivided and challenged with an acid load consisting of NH4Cl powdered into the food 
for 48 h (2 g/100 g food; 40 mM NH4Cl).  At baseline, there were no differences in 
urinary pH or NH4+ excretion between groups.  Differences were noted after the acid load 
was provided.  Acid-loading resulted in significantly lower urinary pH in all groups in 
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comparison to respective controls (Figure 2 A, table 1).  Although most clinical data 
show an acidic urine pH in patients with metabolic syndrome (3, 20, 69), we observed a 
more alkaline urinary pH in O-GI/NH4Cl treated mice than acid-loaded control mice fed 
a standard diet.  Further, there was a small but significant difference in urine volumes 
between cafeteria-fed (both O-GI and NR) and control mice on Day 1 in the metabolic 
cages; however this discrepancy disappeared on Day 2 (table 1).  Low urine volumes 
have also been observed in subjects with UAN (53).  Urinary electrolytes were analyzed 
(table 2). Treatment with NH4Cl resulted in elevated urinary Cl- levels; while at baseline, 
both O-GI and NR groups showed elevated urinary Cl- in comparison to controls.  
Urinary K+ levels were lower in the O-GI group in comparison to controls and further 
decreased after an NH4Cl load.  NR mice also showed reduced urinary K+ during NH4Cl 
administration when compared to NR mice alone and NH4Cl-loaded controls.  Urinary 
phosphate levels were unremarkable between groups, however 24 h phosphate excretion 
relative to urine volume showed reduced phosphate excretion in the O-GI group 
compared to controls (table 2, figure 2 C).  All acid-challenged mice had increased 
urinary NH4+ excretion as expected, however, O-GI mice given NH4Cl had less NH4+ 
excretion relative to urine volume (figure 2 B, table 2 and supplemental figure 2.).   
 
Dysregulation of SNAT3 and key ammoniagenic enzymes in obese, glucose-intolerant 
mice 
 We and others have previously shown that gene expression of SNAT3, and the 
key ammoniagenic enzymes PDG and PEPCK increases after inducing acidosis with 
NH4Cl treatment (12, 16, 18, 32, 39, 57, 60, 75) .  All acid-loaded groups showed 
enhanced SNAT3 mRNA and protein levels (figure 3 A-K), however each group showed 
varying expression.  O-GI mice treated with NH4Cl had considerably higher SNAT3 
mRNA abundance in comparison to controls given NH4Cl (6.7-fold vs 3-fold; table 4).  
SNAT3 protein abundance was exceptionally higher in O-GI/NH4Cl treated mice in 
comparison to NR/NH4Cl treated mice (6.7-fold vs 2.8-fold) despite lower total NH4+ 
excretion.  Similarly, immunoblotting revealed elevated SNAT3 protein abundance in O-
GI/NH4Cl mice when compared to acid-loaded control mice (figure 3 H and I).  PDG 
expression followed similar trends, with increased mRNA expression in all groups treated 
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with NH4Cl (figure 4 A).  Acid-challenged mice (both O-GI and NR) showed relatively 
more PDG protein abundance than respective controls, similar to mRNA expression 
(figure 4 A-E).  O-GI/NH4Cl mice showed markedly elevated PDG mRNA abundance in 
comparison to NR/NH4Cl mice; however no differences were detected on protein level 
(figure 4 A, F-G).  In parallel, PEPCK mRNA expression was markedly enhanced after 
an acid-load (2.5-fold) and in both cafeteria-fed groups; O-GI mice given NH4Cl showed 
the greatest fold change in mRNA expression (4.4-fold vs 2.2—fold; O-GI and NR 
groups, respectively) (table 4).  Protein abundance for PEPCK was also increased after an 
acid load, but similar to PDG, showed no differences among the two acid-loaded 
cafeteria fed groups (figure 5 B-F).   
Daily NH4Cl acid load concentrations were calculated to determine if mice 
received similar acid loads.  Acid-loaded control mice received significantly more NH4Cl 
in the diet in metabolic cages than both cafeteria-fed groups (table 3, supplemental figure 
3 A and B), when calculated based on per gram food/g body weight. Despite this 
discrepancy, there was no major difference in the daily NH4Cl-load between the two 
obese groups despite differences in urinary NH4+ excretion.  Thus, the reduced NH4+ 
excretion in O-GI mice is not due to a reduced dietary acid load. 
 
Dysregulated renal gluconeogenesis likely contributes to reduced NH4+ excretion in 
obese, glucose-intolerant mice   
Renal ammoniagenesis and gluconeogenesis are closely linked in the proximal 
tubule cell.  The series of enzymatic reactions that occur in the conversion of 
phosphoenolpyruvate carboxykinase (PEPCK) to glucose in the proximal tubule cell 
cytosol involve several rate-limiting enzymes, such as fructose 1,6-bisphosphatase and 
fructose 2,6-bisphosphatase (FBP1 and FBP2, respectively).  FBP1 catalyzes the 
conversion of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate, 
and has been recently immunolocalized to PT cells in human kidney (88).  Mutation of 
the FBP1 gene results in a rare gluconeogenic disorder exhibiting symptoms such as 
metabolic acidosis (6).  On mRNA level, we observed a substantial increase in FBP1 
expression in O-GI/NH4Cl treated mice in comparison to O-GI mice without NH4Cl 
treatment (figure 6, A).  We have previously shown that after 2 days of NH4Cl-induced 
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acidosis, FBP2 is down-regulated (60).  Further, we found that FBP2 mRNA was 
significantly down-regulated after 10 weeks of cafeteria style feeding, but only in the 
obese fraction of the group (figure 6 B).  NR mice showed a trend towards decreased 
mRNA expression levels, but no significance could be determined in comparison to 
control mice fed standard chow.  Furthermore, we observed that acid-loading O-GI mice 
produced even greater reductions in FBP2 mRNA in comparison to O-GI in the absence 
of acid-loading. Thus, these data strongly suggest dysregulation of renal gluconeogenesis 
in glucose-intolerant, obese mice.  
In addition to a potential defect in renal gluconeogenesis, we sought to determine 
if there were any distal defects in NH4+ transport in the kidney, in particular of the 
Rhesus glycoprotein, Rhcg, in our mice.  Rhcg is largely expressed in the connecting 
tubule and the collecting duct, and plays an important role in apical NH4+ extrusion into 
the final urine (9, 22, 50, 82).  Rhcg mRNA expression was unremarkable between 
groups, however O-GI mice given an acute acid load showed increased Rhcg mRNA 
expression levels in comparison to O-GI treated without NH4Cl treatment (figure 8).     
 
Brush border membrane sodium-proton exchanger activity is reduced in acid loaded 
obese, glucose-intolerant mice 
To further identify mechanisms that could contribute to a reduction in urinary 
NH4+ excretion, we examined the activity and protein abundance of NHE3 in brush 
border membrane vesicles using an acridine orange quenching method and 
immunoblotting.  Reduced NHE3 activity was observed in acid-loaded O-GI mice (figure 
7A).  In contrast, immunoblotting revealed no significant differences among groups 
(figure 7 B-G).      
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DISCUSSION 
 
We created a mouse model of diet-induced obesity and glucose-intolerance to 
examine if changes in the regulation of the glutamine transporter, SNAT3, and enzymes 
involved in renal ammoniagenesis and gluconeogenesis, PDG and PEPCK could explain 
the urinary acidification and NH4+ excretory defects seen in subjects with UAN and 
diabetes.  After 10 weeks of dietary treatment, cafeteria-diet fed mice fell into two 
distinct cohorts based on body weight and response to IPGTT.  O-GI mice were 
significantly obese and had severely elevated blood glucose, while NR mice were 
moderately obese with more normal blood glucose levels.  Similar observations have 
been previously reported in rats (46-49).  Since we used a highly inbred mouse strain 
(C57BL6) with very little genetic variance in our study, the underlying reason for this 
difference remains unknown at present.  We show that challenging these obese, diabetic 
mice with an oral acid load leads to defective urinary NH4+ excretion despite enhanced 
expression of key ammoniagenic proteins.  O-GI mice exhibited strong upregulation of 
SNAT3, PDG and PEPCK mRNA and protein abundance suggesting enhanced 
ammoniagenesis. This was paralleled by dysregulation of key enzymes of 
gluconeogenesis.  Moreover, the proximal tubular brush border membrane sodium-proton 
exchanger activity was rather reduced in obese and glucose-intolerant mice whereas Rhcg 
mRNA expression appeared normal. 
Studies by Abate et al. and Sakhaee et al. assessed whether or not insulin resistance is 
associated with UAN.  Most patients with UAN had symptoms of metabolic syndrome 
and a low urinary pH, but were without changes in urinary NH4+ excretion.  The NH4+ 
concentration as a major component of net acid excretion, however, was significantly 
reduced in these subjects (1, 69).  Many other clinical studies have observed consistently 
low urinary pH values in patients with UAN and insulin resistance (3, 19, 20, 53). Our 
results show a slightly higher urinary pH and reduced urinary NH4+ excretion in O-GI but 
not NR mice after an acid challenge, despite reduced NH4Cl intake in O-GI mice.  
Importantly, these differences were not observed at baseline and cannot be explained by 
differences in NH4Cl intake.   
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A possible explanation for the higher urinary pH could be attributed to increased 
rates of NH3 diffusion and buffering of H+ in the urine secondary to increased 
ammoniagenesis as we have observed indirectly via increased SNAT3, PDG and PEPCK 
(54).  Further, these observations could be a species specific response to obesity and/or 
insulin resistance.  It should also be noted that previous studies reporting decreased 
urinary pH in patients with metabolic syndrome, sampled urine only over a 4 to 12 hour 
period (36, 69).  In contrast, our samples were collected over 24 hrs and the differences 
may due to changes in circadian rhythm urine and acid excretion. 
 To date, the renal manifestation of insulin resistance is not fully understood.  
Work by Bobulescu et al. found that Zucker diabetic fatty rats exhibit reduced urinary 
NH4+ excretion and pH, as well as reduced NHE3 activity in the renal brush border 
membrane (10).  Interestingly, these rats showed an increase in renal triglyceride content, 
suggesting that there could be a lipotoxic effect of fatty acids in the kidney.  In opossum 
kidney cell lines (OKP), administration of long-chain fatty acids produced a similar 
reduction in NHE3 activity, NHE3 membrane surface expression and NH4+ excretion.  
This led to the hypothesis that the accumulation of lipids, particularly free fatty acids 
(FFA) in the kidney could result in alterations in normal, physiological cellular processes, 
such as ammoniagenesis or gluconeogenesis.  The etiological relationship between 
insulin resistance and low urinary pH has not been identified yet, but it most likely 
involves the proximal tubule.  O-GI mice showed strong upregulation of SNAT3, PDG 
and PEPCK on both protein and mRNA level, which would imply that ammoniagenesis 
and likely gluconeogenesis is being maximally fueled by the influx of glutamine into the 
PT cells.  The increased levels of FBP1 in obese mice are consistent with this 
interpretation.  Under normal physiological conditions,  the liver is the predominate 
gluconeogenic organ, however the kidney can supply the body with relatively additional 
de novo glucose, which can increase substantially during a prolonged fast, starvation or 
hepatic injury (23, 41, 62).  The reason for FBP1 upregulation in obese mice is unclear 
but could be related to relative insulin-resistance of the proximal tubule.    
A defect in the more distal parts of the nephron may also be involved, such as 
reduced excretion of NH4+ and H+ along the collecting duct.  mRNA expression levels of 
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Rhcg, critical for renal ammonium excretion (9), however, did not show significant 
differences between groups. 
In summary, a diet-induced mouse model of obesity and glucose-intolerance 
demonstrates major changes in the regulation of enzymes and transporters involved in 
proximal tubular ammoniagenesis, gluconeogenesis, and NH4+ excretion, and may help to 
explain the urinary defects observed in patients with UAN and diabetes.   
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MATERIAL AND METHODS 
Animals 
 
Male C57BL6 mice (n=72) were randomly assigned to two different dietary 
treatment groups and placed on either a standard diet (control, n = 24) or “cafeteria” style 
diet (n = 48) for 10 weeks.  A cafeteria style diet consists of various combinations of 
energy dense foodstuffs, and is widely used as a model for diet-induced obesity (72).  
Our experimental cafeteria diet consisted of unsalted ground peanuts (40%), cookies 
(25%) and chocolate (15%) mixed with standard rodent chow (20%) to ensure adequate 
macro- and micronutrient composition.  The nutrient composition of the cafeteria diet 
was as follows: 460 kcal, 15 g of protein, 25 g of carbohydrate and 34 g of fat per 100 g 
of ground food.  Mice had ad libitum access to food and water during the 10 week dietary 
treatment period, and were housed in climate controlled and 12 h light-cycled rooms.  All 
mice were weighed weekly.  Animal experiments were conducted according to the Swiss 
animal welfare laws and approved by the Swiss local animal authority, Zurich, 
Switzerland.     
 
Intraperitoneal glucose tolerance tests (IPGTT) 
After 10 weeks of dietary treatment, each mouse was subjected to IPGTT.  The 
test was performed over a 2 h period.  Mice were fasted overnight with free access to 
water.  A single dose of glucose (2 mg/g body weight) was given upon initiation of 
testing, followed by blood collections from the tail vein every 30 minutes.  Glucose 
monitoring was performed using the Accu-chek blood glucose meter (Roche).  After the 
IPGTT, mice were divided into various groups depending on the test outcome: control 
with normal IPGTT; Obese, glucose-intolerant mice with abnormal IPGTT (subsequently 
named: O-GI); or moderately obese with relatively normal IPGTT (Non-Responders, 
NR).  All mice were allowed to recover from the IPGTT for one week, and were 
subsequently housed in metabolic cages for the next series of experiments. 
 
Metabolic cage studies 
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Mice were individually placed in metabolic cages for a total of 4 days, and 
continued on the experimental diets.  Control, O-GI and NR mice were subdivided into 
NH4Cl treated groups; NH4Cl was powdered into the food (2 g/100 g chow) for the final 
48 h.  Food and water intake, body weight and urinary output were monitored daily.  
During the final 48 h of dietary treatment, urine was collected every 24 hours under 
mineral oil and urinary pH was immediately assessed using a pH microelectrode (691 pH 
meter, Metroholm).  The Berthelot and Jaffe methods were used to assess urinary 
NH3/NH4+ and creatinine concentration (7, 74).  At the end of the experimental treatment, 
mice were anesthetized by intraperitoneal injection of ketamine and xylazine, and blood 
was collected in heparinized tubes, immediately centrifuged to extract serum, and frozen 
at -80ºC.  Mice were not perfused prior to harvesting kidneys given that neither SNAT3, 
nor PDG and PEPCK are expressed in whole blood or erythrocytes, respectively (77).  
Although there is some evidence suggesting white blood cells exhibit PDG activity, 
exsanguination caused by the blood collections minimized the likelihood of blood cell 
contamination in our preparations (14, 15, 65).  Kidneys were harvested, flash-frozen in 
liquid nitrogen, and transferred to a -80ºC freezer until further use. 
 
Quantitative Real-time RT PCR 
Previously frozen kidneys were homogenized using a Rotor-stator homogenizer, 
and RNA was immediately extracted using Qiagen RNeasy Mini Kit (Qiagen; Hilden, 
Germany).  DNase digestion was performed using the RNase-free DNase Set (Qiagen; 
Hilden, Germany).  Total RNA extractions were analyzed using the NanoDrop ND-1000 
spectophotometer (Wilmington, DE, USA).  cDNA was prepared from diluted RNA 
samples (100 ng/µl) using the TaqMan Reverse Transcriptase Reagent Kit containing 
10X RT buffer, MgCl2, random hexamers, dNTPs, RNase inhibitors and Multiscribe 
reverse transcription enzyme (Applied Biosystems/Roche; Forster City, CA, USA). 
Thermocycling conditions for reverse transcription were set at 25ºC for 10 min, 48ºC for 
30 min, and 95ºC for 5 min (Biometra TGradient thermocycler, Goettingen, Germany).  
Quantitative Real-time RT-PCR was used to determine relative mRNA expression (7500 
Fast Real-Time PCR system, Applied Biosystems).  Thermocycling conditions were set 
at: 50 ºC (2 min), 95ºC (10 min), 95 ºC (15 sec; 40 cycles) and 60 ºC (1 min).  Forward 
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and reverse primer concentration was 25 µM; probe concentration was 5 µM.  TaqMan 
Universal PCR master mix 2X (Applied Biosystems/Roche) was used as the Taq 
polymerase.  Primers and probes for SNAT3, phosphate dependent glutaminease (PDG), 
phosphoenolpyruvate carboxykinase (PEPCK), fructose 2,6-bisphosphatase (FBP2), 
rhesus glycoprotein (Rhcg) and Hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) were generated using the Primer Express software from Applied Biosystems and 
synthesized at Microsynth (Balgach, Switzerland) as described previously (60).  The 
primer and probe sequences for fructose 2,6-bisphosphatase (FBP1) are as follows: 5’-
CAA TGA GTA TCT CCA GAG GAA AA A GTT-3’, forward primer; 5’-CCA CAT 
ACC GGG CAC CAT-3’, reverse primer; CCT CCG GAT GGT TCA GCC CCC-3’, 
probe.  For Rhcg: 5’-GTT GGA GAA GAA GCG CAA GAA-3’, forward; 5’-CGA AGA 
CCA TGG CGT GTA CA-3’, reverse; 5’-TTA CTA TCG CTA CCC GAG CTT CCA G-
3’, probe.  Probes were generated with the reporter dye FAM at the 5’ end and TAMRA 
at the 3’ end.  Each sample was run in triplicate including a negative control (without 
Multiscribe reverse transcription enzyme).  The cycle threshold (Ct) values obtained were 
ultimately compared to Ct values of the endogenous gene HPRT.  Relative mRNA 
expression ratios were calculated as R=2[Ct(HPRT)-Ct(gene of interest)].   
 
Immunoblotting 
Total membrane and cytosolic protein preparations were prepared from whole, 
non-perfused kidneys using a K-HEPES buffer composed of 200 mM mannitol, 80 mM 
HEPES, 41 mM KOH, along with the protease inhibitors, PMSF, K-EDTA, and leupeptin 
(pH 7.5).  Kidneys were homogenized in 200 µl of ice-cold K-HEPES buffer using a tip 
sonicator and immediately centrifuged at 2000 rpm for 20 min (4ºC).  The supernatant 
was aspirated and placed in an ultracentrifuge (Sorvall, Thermo Fischer Scientific) for 1 h 
at 41,000 rpm 4ºC.  The supernatant containing cytosolic protein from this second 
centrifugation step was removed and the pellet containing membrane protein was 
resuspended in K-HEPES buffer and sonicated to evenly distribute proteins.  The BioRad 
Dc Protein assay was used to measure protein concentration (Bio-Rad; Hercules, CA, 
USA).  Total membrane (75 µg) or cytosolic (50 µg) protein containing Laemmli sample 
buffer and loaded onto a 10% polyacrylamide gel and SDS-PAGE was performed.  
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Proteins were transferred to polyvinylidene difluoride membranes (PVDF; Immobilon-P, 
Millipore, Bedford, MA, USA).  Membranes were blocked with Tris-buffered saline / 
0.1% Tween and 5% non-fat dry milk for 1 h.  Primary antibodies were applied for 2 h at 
RT or overnight at 4ºC.  The primary antibodies used for this study were: phosphate-
dependent glutaminase (PDG), which recognizes both the rat (KGA) and human (GAC) 
kidney-type isoforms of PDG forming the mature PDG protein (66 and 68 kDa; a kind 
gift from N. Curthoys, Colorado State University, USA; diluted 1:500) (17); anti-PEPCK 
polyclonal antibody (63 kDa; Cayman Chemical, Ann Arbor, MI, USA; diluted 1:1,000), 
and mouse monoclonal antibody against β-actin (42 kDa; Sigma, St. Louis, MO, USA; 
diluted 1:5,000).  The anti-NHE3 antibody (90 kDa; a kind gift from O. Moe) diluted 
1:5000).  The anti-Slc38a3 antibody (1:500) was generated as previously described (57).  
The secondary antibodies used were anti-rabbit alkaline phosphatase conjugated diluted 
1:5,000, and anti-mouse IgG alkaline phosphatase conjugated diluted 1:5,000 or anti-
mouse IgG horseradish peroxidase-conjugated 1:10,000, and donkey anti-rabbit HRP 
1:12,000.  After a series of washing steps and blocking, membranes were treated with 
alkaline phosphatase- or horseradish peroxidase-conjugated developing solution 
(Imobilion, location) and exposed to the Diana III chemiluminescence detection system 
(Raytest).  Specific bands on PVDF membranes were later quantified using AIDA Image 
analyzer version 3.44.  Membranes were stripped and reprobed for anti-β-actin and 
subsequent analysis of the protein of interest was determined relative to β-actin 
quantification and reported as relative protein abundance (ratio of β-actin/protein of 
interest).  
 
 
Brush border membrane acridine orange quenching experiments 
Renal brush border membrane vesicle preparations (BBMV) were prepared as 
previously described (8).  Briefly, kidneys were cut into small sections and homogenized 
using a Polytron homogenizer with a fine rod for 2 minutes in a buffer containing: 300 
mM mannitol, 5 mM EGTA and 12 mM Tris-HCl, pH 7.1.  A fraction of the 
homogenates was stored at -20 ºC for immunoblotting, while 1 M MgCl2 was added to 
the remaining homogenate and allowed to precipitate on ice for 15 minutes.  The sample 
 67
was then centrifuged at 4500 rpm for 15 minutes.  The supernatant was aspirated and 
centrifuged at 18000 rpm for 30 minutes.  The pellet was resuspended in membrane 
buffer consisting of: 300 mM mannitol, 20 mM HEPES-Tris, pH 7.4.  Samples were then 
centrifuged at 18500 rpm for 30 minutes.  Vesicle buffer was added to samples, 
containing: 280 mM mannitol, 5 mM MES/N-methyl-D-glutamine and 2 mM MgCl2, pH 
5.5.  Protein concentration was measured using the BioRad fast method.   
Acridine orange quenching measurements were performed as previously 
described (31).  Briefly, BBMV suspensions (30 µl) and 6 µM of acridine orange dye 
were added to a spectrofluometer cuvette held at 25ºC.  Excitation occurred at 493 nm 
and emission at 530 nm.  NHE activity was calculated as the as the ∆ pH per minute over 
Q, where Q represents the quenching of acridine orange detected upon addition of sodium 
gluconate to the cuvette (2 M).       
Statistical analyses were performed using unpaired Student’s t-test, and results 
with p < 0.05 were considered statistically significant.  Data are reported as means ± 
SEM.                  
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FIGURE LEGENDS 
Table 1 
 
Intake and output was measured in control and cafeteria-fed mice for the final 
consecutive 24 hours of experimental dietary treatment, with or without NH4Cl 
supplementation in the food.  Values are means ± SE of results (n = 8 mice per group).    
aP ≤ 0.05; bP ≤ 0.01; cP ≤ 0.001, comparisons between control and treated groups.  dP ≤ 
0.05; eP ≤ 0.01; fP ≤ 0.001, comparisons between cafeteria-fed groups.  gP ≤ 0.05; hP ≤ 
0.01; iP ≤ 0.001, comparisons between acid-loaded groups. 
 
Table 2 
Urine analyses were performed to determine the effect of cafeteria style feeding and 
NH4Cl treatment on urinary parameters.  Values are means ± SE of results from analyses 
for urinary electrolytes, PO43- and NH4+ relative to creatinine in mice (n = 8 mice per 
group) treated with a standard or cafeteria diet for 10 weeks, with or without NH4Cl 
supplementation in the food for the final 2 days.  aP ≤ 0.05; bP ≤ 0.01; cP ≤ 0.001, 
comparisons between control and treated groups.  dP ≤ 0.05; eP ≤ 0.01; fP ≤ 0.001, 
comparisons between cafeteria-fed groups.  gP ≤ 0.05; hP ≤ 0.01; iP ≤ 0.001, comparisons 
between acid-loaded groups. 
 
Table 3 
Mean calculated 24 h dietary NH4Cl load per g food/g body weight in acid-loaded mice 
fed either a control or cafeteria diet for 10 weeks.  Values are means ± SE of results from 
individual mice given an NH4Cl acid load for the final 48 h in metabolic cages  
(0.4 mM/g food).  The average concentration of NH4Cl ingested is calculated relative to 
daily food intake in grams per gram of body weight.  aP ≤ 0.05; comparisons between 
cafeteria-fed mice on Day 2.  bP ≤ 0.01; cP ≤ 0.001; comparisons between control and 
cafeteria-fed groups on Day 1 or 2.    
 70
Table 4 
Fold change in mRNA expression in mice in response to NH4Cl treatment.  Mice were 
placed on either a control or cafeteria diet for 10 weeks.  mRNA abundances were 
determined using quantitative real-time RT PCR in total kidneys.  Values represent fold 
changes in mean Ct values for each gene of interest relative to the reference gene HPRT, 
and comparisons made between respective controls.   
 
Figure 1 
Two tiers of glucose intolerance are unmasked in cafeteria-fed mice after 
intraperitoneal glucose tolerance testing.  Intraperitoneal glucose tolerance tests were 
performed on all mice (n = 72) after 10 weeks of a standard or cafeteria diet.  Mice were 
fasted overnight and blood glucose monitoring was performed every 30 minutes for 2 h 
after an initial glucose injection (2mg/g body weight), (A).  The most severely glucose-
intolerant mice were subsequently named obese, glucose-intolerant (O-GI), while the 
second tier of mice had moderately elevated blood glucose levels and were called the 
non-responders (NR).  A weight differential was determined between O-GI and NR mice 
(B).  O-GI mice were significantly more obese than control or NR mice.   
 
Figure 2 
Acid challenging cafeteria-fed mice with NH4Cl reveals a defect in ammonium 
excretion and urinary acidification in O-GI mice.   
Mice were placed in metabolic cages and urine was collected for the final two 
consecutive 24 h intervals under mineral oil.  All acid-loaded groups exhibited low 
urinary pH values in comparison to respective controls, however O-GI mice showed a 
slightly more alkaline urine than NH4Cl-loaded mice fed a standard diet (A).  24 h 
urinary ammonium (B) and phosphate (C) excretion relative to creatinine was 
significantly reduced in O-GI, but not NR mice. 
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Figure 3 
O-GI mice show strong upregulation of SNAT3 mRNA and protein abundance after an 
acid challenge with NH4Cl. 
mRNA expression of SNAT3 was determined in kidneys using quantitative real-time RT 
PCR in mice fed a standard or cafeteria diet for 10 weeks with or without NH4Cl 
supplementation in food, and normalized against HPRT mRNA expression.  All acid-
loaded groups showed enhanced SNAT3 mRNA expression, with the O-GI group 
showing a strong upregulation of SNAT3 (A).  Total membranes were extracted from 
whole, non-perfused kidney, and membranes were probed with an N-terminal antibody 
against SNAT3 and reprobed after stripping for β-actin to control for equal loading.  
Original blots are depicted with bar graphs summarizing normalized data.  Enhanced 
SNAT3 protein abundance was observed after 2 days of NH4Cl treatment, (B, C).  
SNAT3 protein abundance is upregulated after 10 weeks of cafeteria feeding and 2 days 
of NH4Cl supplementation in O-GI (D,E) and NR (F,G) mice.  O-GI mice given NH4Cl 
showed the most SNAT3 protein abundance in comparison to acid-loaded controls (H,I) 
or acid-loaded NR mice (J,K).  *P ≤ 0.05, **P  ≤ 0.01, and ***P ≤ 0.001 between 
groups. 
 
Figure 4 
Phosphate-dependent glutaminase is strongly enhanced in O-GI mice after an acid-
load. 
mRNA expression of PDG was determined using quantitative real-time RT PCR.  PDG 
mRNA was enhanced in all groups after an acid load, and most strongly in the O-GI 
group given NH4Cl when compared to acid-loaded control and NR mice (A).  Cytosolic 
proteins were extracted from whole, non-perfused kidneys and probed for PDG.  O-GI 
(B,C) and NR (D,E) mice given NH4Cl had increased PDG protein abundance in 
comparison to respective controls, however no differences were observed between acid-
loaded O-GI and NR groups when immunoblotted together (F,G). *P ≤ 0.05, **P  ≤ 0.01  
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Figure 5 
Phosphoenolpyruvate carboxykinase mRNA expression and protein abundance 
parallel PDG in cafeteria-fed mice. 
RNA was extracted from total kidney homogenates and mRNA expression was 
determined by quantitative real-time RT PCR.  PEPCK mRNA expression was elevated 
in all acid-loaded groups, however both cafeteria fed groups showed the greatest increase 
in mRNA expression (A).  Cytosolic protein fractions were prepared from whole, non-
perfused kidneys.  Similarly, both O-GI (B,C) and NR (D,E) mice given an acid-load had 
the greatest increases in PEPCK protein abundance in comparison to O-GI and NR mice 
without NH4Cl supplementation.  No differences were detected when both acid-loaded 
cafeteria groups were immunoblotted together (E,F).  *P ≤ 0.05, **P  ≤ 0.01, and ***P ≤ 
0.001 between groups. 
 
Figure 6 
Gluconeogeneogenic enzyme activity is regulated by cafeteria diet feeding 
RNA was extracted from whole, non-perfused kidneys from mice on a standard or 
cafeteria diet for 10 weeks, with and without NH4Cl supplementation.  Quantitative real-
time RT PCR was used to determine mRNA expression.  Fructose 1,6-bisphosphatase 
(FBP1) was significantly increased in all cafeteria-fed mice (A).  In contrast, fructose 2,6-
bisphosphatase (FBP2) was regulated only in the O-GI groups, showing reduced mRNA 
expression in the O-GI group compared to mice fed a standard diet (B).  Acid-loaded O-
GI mice had significantly less FBP2 mRNA expression than O-GI mice alone.  *P ≤ 0.05, 
**P  ≤ 0.01  between groups.    
 
Figure 7 
Sodium/hydrogen exchanger 3 activity is reduced in BBMV from acid-loaded O-GI 
mice. 
BBMV preparations were made and acridine orange quenching experiments were 
performed (A).  O-GI mice given an NH4Cl load had reduced NHE3 activity relative to 
respective controls.  In contrast, acid-loaded NR mice showed enhanced NHE3 activity 
when compared with NR mice without NH4Cl treatment.  Total membrane preparations 
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were made from whole, non-perfused kidneys and immunoblotted for NHE3 protein.  No 
changes were observed among the groups (HAVE TO ADD IN THE WB AND 
QUANTIFICATIONS) (B-G).   *P ≤ 0.05, **P  ≤ 0.01, and ***P ≤ 0.001 between 
groups. 
    
Figure 8 
Reduced NH4 excretion observed in O-GI mice is not likely due to alterations in distal 
NH4  transport. 
mRNA expression of Rhcg was determined in all groups.  No significant changes were 
noted among groups, indicating the defect in NH4 excretion is more proximal. *P ≤ 0.05 
between groups.               
 
Supplemental figure 1 
Cafeteria fed mice show rapid weight gain over the 10-week experimental period. 
Body weights of all mice were measured weekly for 10 weeks.  A weight differential was 
observed between cafeteria diet mice.  O-GI mice gained the most weight, while NR mice 
had only modest weight gain. 
 
Supplemental figure 2 
All acid-loaded mice showed appropriate urinary responses to the acid challenge. 
24 h urinary NH4 excretion was determined in all mice.  O-GI/NH4Cl mice showed 
significantly less NH4 excretion than NR/NH4Cl treated mice.  Urine volume was not  
included in the calculation.  *P ≤ 0.05, **P  ≤ 0.01, and ***P ≤ 0.001 between groups. 
 
Supplemental figure 3 
Cafeteria-fed mice received less NH4Cl in the food due to reduced food intake at the 
end of the experimental period. 
Mean NH4Cl load was calculated based on individual food intakes and body weight.  O-
GI and NR mice ate less food and therefore ingested less NH4Cl than controls.  This was 
observed on both Day 1 (A) and Day 2 (B) in the metabolic cages.   *P ≤ 0.05, **P  ≤ 
0.01, and ***P ≤ 0.001 between groups. 
Table 1 
Metabolic cage studies: differences in intake and output in control and cafeteria-fed mice  
Final consecutive 24 h intervals 
 
Values are means ± SE of results from analyses from metabolic cage studies with mice (n = 8 mice per group) treated with a standard or cafeteria diet for 10 
weeks, with or without NH4Cl supplementation in the food for the final 2 days.  aP ≤ 0.05; bP ≤ 0.01; cP ≤ 0.001, comparisons between control and treated 
groups.  dP ≤ 0.05; eP ≤ 0.01; fP ≤ 0.001, comparisons between cafeteria-fed groups.  gP ≤ 0.05; hP ≤ 0.01; iP ≤ 0.001, comparisons between acid-loaded groups. 
   
Groups Control NH4Cl 2 days O-GI O-GI/NH4Cl 2 days  NR NR/NH4Cl 2 days 
 
 
Initial body weight 
(bw) after IPGTT 
31.3 ± 0.6  43.5 ± 0.9c  37.8 ± 1.4c,e  
DAY 1        
Food intake g/g bw 0.11 ± 0.01 0.07 ± 0.01c 0.04 ± 0.002c 0.03 ± 0.004e,i 0.05 ± 0.004c 0.04 ± 0.01i 
Water intake g/g bw 0.18 ± 0.01 0.14 ± 0.01a 0.13 ± 0.03 0.09 ± 0.01h 0.10 ± 0.01c 0.13 ± 0.02d 
Urine output ml/g bw 0.04 ± 0.01 0.04 ± 0.01 0.03 ± 0.002b 0.03 ± 0.004 0.03 ± 0.004a 0.04 ± 0.01 
Urine pH 6.17 ± 0.12 5.78 ± 0.04b 6.24 ± 0.07 6.09 ± 0.17d 6.07 ± 0.06 5.87 ± 0.07d 
Body wt (g) 30.7 ± 0.61 30.05 ± 1.02 43.75 ± 1.45c 42.53 ± 0.66i 40.06 ± 1.49c  38.05 ± 2.51g 
       
DAY 2       
Food intake g/g bw 0.12 ± 0.01 0.09 ± 0.01a 0.05 ± 0.003c 0.03 ± 0.003e,i 0.06 ± 0.004c 0.05 ± 0.01e,i 
Water intake g/g bw 0.19 ± 0.01 0.19 ± 0.02 0.09 ± 0.01c 0.11 ± 0.01h 0.10 ± 0.01c 0.15 ± 0.02d 
Urine output ml/g bw 0.05 ± 0.01 0.04 ± 0.01 0.02 ± 0.003a 0.03 ± 0.003g 0.03 ± 0.01 0.03 ± 0.003 
Urine pH 6.28 ± 0.14 5.84 ± 0.04b 6.38 ± 0.05 6.01 ± 0.05g 6.42 ± 0.21 5.90 ± 0.06 
Body wt (g) 30.63 ± 0.61 29.51 ± 1.01 42.98 ± 1.39c 41.62 ± 0.68i  39.59 ± 1.43c 37.04 ± 2.42g 
       
        
 
Table 2 
Urinary analyses: effect of cafeteria-style feeding and NH4Cl administration 
 
 
Values are means ± SE of results from analyses for urinary electrolytes and PO43- and NH4+ relative to creatinine in mice (n = 7-8 mice per group) treated with a 
standard or cafeteria diet for 10 weeks, with or without NH4Cl supplementation in the food for the final 2 days.  aP ≤ 0.05; bP ≤ 0.01; cP ≤ 0.001, comparisons 
between control and treated groups.  dP ≤ 0.05; eP ≤ 0.01; fP ≤ 0.001, comparisons between cafeteria-fed groups.  gP ≤ 0.05; hP ≤ 0.01; iP ≤ 0.001, comparisons 
between acid-loaded groups. 
 
 
   
Groups 
Electrolytes  
Control NH4Cl 2 days O-GI O-GI/NH4Cl 2 days NR NR/NH4Cl 2 days  
Na+, mM 1.07 ± 0.15 0.74 ± 0.09 0.71 ± 0.14 0.48 ± 0.08 0.93 ± 0.24 0.53 ± 0.09 
K+, mM 3.27 ± 0.44 2.38 ± 0.33 1.5 ± 0.24b 1.06 ± 0.22h 2.30 ± 0.43 1.24 ± 0.17d,h 
Ca2+, mM 0.036 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 
Mg2+, mM 0.25 ± 0.03 0.20 ± 0.03 0.17 ± 0.05 0.15 ± 0.04 0.19 ± 0.04 0.20 ± 0.04 
Cl-, mM 2.31 ± 0.42 5.12 ± 0.54b 0.91 ± 0.14a 3.25 ± 0.71e 1.07 ± 0.12a 4.1 ± 0.32f 
PO43-, mM 0.72 ± 0.11 0.63 ± 0.10 0.69 ± 0.12 0.63 ± 0.15 0.95 ± 0.06 0.95 ± 0.19 
SO42-, mM 0.48 ± 0.10 0.37 ± 0.04 0.24 ± 0.04a 0.21 ± 0.05g 0.30 ± 0.04 0.21 ± 0.02h 
       
PO43-/creatinine 
mmol·mg-1·dl 
0.782 ± 0.107 0.974 ± 0.13 0.957 ± 0.08 1.082 ± 0.154 1.103 ± 0.062 1.145 ± 0.189 
PO43-, mmol/ 24 h  0.094 ± 0.013 0.092 ± 0.015 0.057 ± 0.088a 0.067 ± 0.007 0.085 ± 0.014 0.065 ± 0.004 
 NH4+/creatinine 
mmol·mg-1·dl 
0.595 ± 0.238 6.21 ± 1.12c 0.691 ± 0.107 4.591 ± 0.722f 2.085 ± 0.755 6.886 ± 0.745f,g 
NH4+, mmol/24 h 0.095 ± 0.045 0.577 ± 0.114b 0.041 ± 0.009 0.312 ± 0.03f,g 0.092 ± 0.026 0.481 ± 0.078f 
       
       
       
 
 
       
Table 3   
Mean calculated 24 h dietary NH4Cl load per g food/g body weight in acid-loaded mice  
 
 
 
 
 
 
 
 
 
Values are means ± SE of results from individual mice given an NH4Cl acid load for the final 48 h in metabolic cages  
(0.4 mM/g food).  The average concentration of NH4Cl ingested is calculated relative to daily food intake in grams per 
gram of body weight.  aP ≤ 0.05; comparison among cafeteria-fed mice on Day 2.  bP ≤ 0.01; cP ≤ 0.001; comparisons  
among control and cafeteria-fed groups on Day 1 or 2.        
 
 
 
 
Groups Day 1 Day 2 
NH4Cl 2 days 0.029 mM ± 0.003 0.037 mM ± 0.003 
O-GI/NH4Cl 2 days 0.011 mM ± 0.002c 0.012 mM ± 0.001c 
NR/NH4Cl 2 days 0.016 mM ± 0.003b 0.018 mM ± 0.002a,c 
   
 
Table 4 
Fold change in mRNA expression in mice in response to NH4Cl treatment 
 
 
 
 
 
 
 
 
 
 
 
 
Values represent fold changes in mean Ct values for each gene of interest relative to the reference gene HPRT.   
  
Groups 
mRNA expression 
Control vs  
NH4Cl 2 days 
O-GI vs  
O-GI/NH4Cl 2 days 
NR vs  
NR/NH4Cl 2 days 
SNAT3 3.04 6.70 2.83 
PDG 1.69 3.51 1.74 
PEPCK 2.51 4.43 2.24 
FBP1 0.76 1.46 1.09 
FBP2 1.12 0.55 0.92 
Rhcg 1.26 1.30 1.08 
    
 
Figure 1 Busque et al.
A.
B.
control
O-GI
NR
m
ea
n 
bo
dy
 w
ei
gh
t (
g)
0 30 60 90 120
50
150
250
350
450
550
control
O-GI
NR
a
a,d
c,d
c
c,d
c
c,d
c
c,d
time interval (minutes)
bl
oo
d 
gl
uc
os
e 
(m
g/
dl
)
b
Glc
20
30
40
50
***
*** **
Figure 2 Busque et al.
A.
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
5
6
7
** ** *
*
ur
in
ar
y 
pH
B.
0.00
0.25
0.50
0.75
**
***
***
*
N
H
4+
ex
cr
et
io
n 
m
m
ol
/2
4 
h
C.
0.00
0.05
0.10
0.15
*
ph
os
ph
at
e 
ex
cr
et
io
n 
m
m
ol
/ 2
4 
h
Busque et al.Figure 3
A.
1
2
3
4
5 ***
*
*
*
SNAT3
2^
(H
P
R
T-
S
N
A
T3
)
SNAT3 55
42
control NH4Cl 2 days
SNAT3
O-GI/NH4Cl 2 daysO-GI
β-actin
NR NR/NH4Cl 2 days
SNAT3
β-actin
B.
D.
F.
C.
E.
G.
β-actin
55
55
42
42
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
control NH4Cl-2d
0
1
2
3
4 *
O-GI O-GI/
NH4Cl-2d
***
0
1
2
3
4
no
rm
al
iz
ed
 re
la
tiv
e
SN
AT
3 
ab
un
da
nc
e
no
rm
al
iz
ed
 re
la
tiv
e
SN
AT
3 
ab
un
da
nc
e
*
NR NR/
NH4Cl-2d
0
1
2
3
4
no
rm
al
iz
ed
 re
la
tiv
e
SN
AT
3 
ab
un
da
nc
e
Busque et al.Figure 3
O-GI/NH4Cl 2 days NR/NH4Cl 2 days
SNAT3
β-actin
NH4Cl 2 days O-GI/NH4Cl 2 days
SNAT3
β-actin
H.
J.
K.
I.
55
55
42
42 *
no
rm
al
iz
ed
 re
la
tiv
e
SN
AT
3 
ab
un
da
nc
e
0
1
2
3
4
NH4Cl-2d
***
O-GI/
NH4Cl-2d
O-GI/
NH4Cl-2d
NR/
NH4Cl-2d
0
1
2
3
4
no
rm
al
iz
ed
 re
la
tiv
e
SN
AT
3 
ab
un
da
nc
e
A.
0.0
2.5
5.0
7.5
**
*
*
**
PDG
*
2^
(H
P
R
T-
P
D
G
)
Figure 4 Busque et al.
PDG
PDG
PDG
β-actin
O-GI/NH4Cl 2 daysO-GI
NR/NH4Cl 2 daysNR
β-actin
NR/NH4Cl 2 daysO-GI/NH4Cl 2 days
β-actin
B.
D.
F.
C.
E.
G.
66
68
42
66
68
42
66
68
42
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
0.0
0.5
1.0
1.5 **
O-GI O-GI/
NH4Cl-2d
no
rm
al
iz
ed
 re
la
tiv
e
PD
G
 a
bu
nd
an
ce
0.0
0.5
1.0
1.5
no
rm
al
iz
ed
 re
la
tiv
e
PD
G
 a
bu
nd
an
ce
NR NR/
NH4Cl-2d
0.0
0.5
1.0
1.5
no
rm
al
iz
ed
 re
la
tiv
e
PD
G
 a
bu
nd
an
ce
O-GI/
NH4Cl-2d
NR/
NH4Cl-2d
Figure 5 Busque et al.
PEPCK
PEPCK
O-GI/NH4Cl 2 daysO-GI
β-actin
NR/NH4Cl 2 daysNR
PEPCK
β-actin
NR/NH4Cl 2 daysO-GI/NH4Cl 2 days
β-actin
0
100
200
300
400
*** *
**
**
*
PEPCK
2^
(H
P
R
T-
P
E
P
C
K
)
A.
B.
D.
E.
C.
E.
F.
63
63
63
42
42
42
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
no
rm
al
iz
ed
 re
la
tiv
e
PE
PC
K 
ab
un
da
nc
e
0.0
0.5
1.0
1.5
O-GI O-GI/
NH4Cl-2d
0
1
2
3
no
rm
al
iz
ed
 re
la
tiv
e
PE
PC
K 
ab
un
da
nc
e
NR NR/
NH4Cl-2d
0.0
0.5
1.0
1.5
no
rm
al
iz
ed
 re
la
tiv
e
PE
PC
K 
ab
un
da
nc
e
O-GI/
NH4Cl-2d
NR/
NH4Cl-2d
Figure 6 Busque et al.
A.
FBP2
0.0
0.1
0.2
0.3
**
*
2^
(H
P
R
T-
FB
P
2)
B.
FBP1
0
25
50
75
**
*
80
95
110
*
**
**
2^
(H
P
R
T-
FB
P
1) control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
NHE3
β-actin
Figure 7 Busque et al.
0
1
2
3
****
B
B
M
V
 
ac
rid
in
e 
or
an
ge
 
qu
en
ch
in
g 
(F
u/
t/Q
)
A.
B.
D.
F.
C.
E.
G.
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
β-actin
NHE3
β-actin
NHE3
O-GI O-GI/NH4Cl 2 days
NR NR/NH4Cl 2 days
control NH4Cl 2 days
96
96
96
42
42
42
no
rm
al
iz
ed
 re
la
tiv
e
N
H
E3
 a
bu
nd
an
ce
0
1
2
control NH4Cl-2d
0
1
2
3
4
no
rm
al
iz
ed
 re
la
tiv
e
N
H
E3
 a
bu
nd
an
ce
NR NR/
NH4Cl-2d
no
rm
al
iz
ed
 re
la
tiv
e
N
H
E3
 a
bu
nd
an
ce
0
1
2
O-GI O-GI/
NH4Cl-2d
Rhcg
0
1
2
3
4
*
2^
(H
P
R
T-
R
hc
g)
Figure 8 Busque et al.
control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
Supplemental Figure 1 Busque et al.
control
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
NH4Cl 2 days
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
O-GI
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
O-GI/NH4Cl 2 days
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
NR
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
NR/NH4Cl 2 days
0 1 2 3 4 5 6 7 8 9 10
20
25
30
35
40
45
50
weeks
w
ei
gh
t (
g)
Supplemental Figure 2 Busque et al.
0.0
2.5
5.0
7.5
10.0
***
*
N
H
4+
/c
re
at
in
in
e 
m
m
ol
x 
m
g-
1 x
 d
l
*** *** control
NH4Cl 2 days
O-GI
O-GI/NH4Cl 2 days
NR
NR/NH4Cl 2 days
0.00
0.01
0.02
0.03
0.04
NH4Cl 2 days
O-GI/NH4Cl 2 days
NR/NH4Cl 2 days
***
**
DAY 1
N
H
4C
l l
oa
d 
(m
M
)
g 
fo
od
/g
 b
od
y 
w
t
0.00
0.01
0.02
0.03
0.04
***
***
*
DAY 2
N
H
4C
l l
oa
d 
(m
M
)
g 
fo
od
/g
 b
od
y 
w
t
A.
B.
Supplemental Figure 3 Busque et al.
 74
REFERENCES 
1. Abate N, Chandalia M, Cabo-Chan AV, Jr., Moe OW, and Sakhaee K. The 
metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of 
insulin resistance. Kidney international 65: 386-392, 2004. 
2. Ambuhl PM, Amemiya M, Danczkay M, Lotscher M, Kaissling B, Moe OW, 
Preisig PA, and Alpern RJ. Chronic metabolic acidosis increases NHE3 protein 
abundance in rat kidney. The American journal of physiology 271: F917-925, 1996. 
3. Asplin JR. Uric acid stones. Seminars in nephrology 16: 412-424, 1996. 
4. Association AD. http://www.diabetes.org/diabetes-statistics/prevalence.jsp. 
[March 31, 2009 
5. Attmane-Elakeb A, Mount DB, Sibella V, Vernimmen C, Hebert SC, and 
Bichara M. Stimulation by in vivo and in vitro metabolic acidosis of expression of 
rBSC-1, the Na+-K+(NH4+)-2Cl- cotransporter of the rat medullary thick ascending 
limb. The Journal of biological chemistry 273: 33681-33691, 1998. 
6. Baker L, and Winegrad AI. Fasting hypoglycaemia and metabolic acidosis 
associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet 2: 13-
16, 1970. 
7. Berthelot M. Violet d'aniline. Rep Chim App 1: 284, 1859. 
8. Biber J, Stieger B, Stange G, and Murer H. Isolation of renal proximal tubular 
brush-border membranes. Nature protocols 2: 1356-1359, 2007. 
9. Biver S, Belge H, Bourgeois S, Van Vooren P, Nowik M, Scohy S, Houillier P, 
Szpirer J, Szpirer C, Wagner CA, Devuyst O, and Marini AM. A role for Rhesus 
factor Rhcg in renal ammonium excretion and male fertility. Nature 456: 339-343, 2008. 
10. Bobulescu IA, Dubree M, Zhang J, McLeroy P, and Moe OW. Effect of renal 
lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. 
American journal of physiology 294: F1315-1322, 2008. 
11. Burch HB, Narins RG, Chu C, Fagioli S, Choi S, McCarthy W, and Lowry 
OH. Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis 
and starvation. The American journal of physiology 235: F246-253, 1978. 
 75
12. Busque SM, and Wagner CA. Potassium restriction, high protein intake, and 
metabolic acidosis increase expression of the glutamine transporter SNAT3 (Slc38a3) in 
mouse kidney. American journal of physiology 2009. 
13. Cimbala MA, Lamers WH, Nelson K, Monahan JE, Yoo-Warren H, and 
Hanson RW. Rapid changes in the concentration of phosphoenolpyruvate carboxykinase 
mRNA in rat liver and kidney. Effects of insulin and cyclic AMP. The Journal of 
biological chemistry 257: 7629-7636, 1982. 
14. Costa Rosa LF, Curi R, Murphy C, and Newsholme P. Effect of adrenaline 
and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways 
of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP-
dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and 
activation of NADP+-dependent 'malic' enzyme. The Biochemical journal 310 ( Pt 2): 
709-714, 1995. 
15. Curi TC, De Melo MP, De Azevedo RB, Zorn TM, and Curi R. Glutamine 
utilization by rat neutrophils: presence of phosphate-dependent glutaminase. The 
American journal of physiology 273: C1124-1129, 1997. 
16. Curthoys NP, and Gstraunthaler G. Mechanism of increased renal gene 
expression during metabolic acidosis. American journal of physiology 281: F381-390, 
2001. 
17. Curthoys NP, Kuhlenschmidt T, Godfrey SS, and Weiss RF. Phosphate-
dependent glutaminase from rat kidney. Cause of increased activity in response to 
acidosis and identity with glutaminase from other tissues. Archives of biochemistry and 
biophysics 172: 162-167, 1976. 
18. Curthoys NP, and Lowry OH. The distribution of glutaminase isoenzymes in 
the various structures of the nephron in normal, acidotic, and alkalotic rat kidney. The 
Journal of biological chemistry 248: 162-168, 1973. 
19. Daudon M, Lacour B, and Jungers P. High prevalence of uric acid calculi in 
diabetic stone formers. Nephrol Dial Transplant 20: 468-469, 2005. 
20. Daudon M, Traxer O, Conort P, Lacour B, and Jungers P. Type 2 diabetes 
increases the risk for uric acid stones. J Am Soc Nephrol 17: 2026-2033, 2006. 
 76
21. DeFronzo RA, Cooke CR, Andres R, Faloona GR, and Davis PJ. The effect of 
insulin on renal handling of sodium, potassium, calcium, and phosphate in man. The 
Journal of clinical investigation 55: 845-855, 1975. 
22. Eladari D, Cheval L, Quentin F, Bertrand O, Mouro I, Cherif-Zahar B, 
Cartron JP, Paillard M, Doucet A, and Chambrey R. Expression of RhCG, a new 
putative NH(3)/NH(4)(+) transporter, along the rat nephron. J Am Soc Nephrol 13: 1999-
2008, 2002. 
23. Faus MJ, Lupianez A, Vargas A, and Sanchez-Medina F. Induction of rat 
kidney gluconeogenesis during acute liver intoxication by carbon tetrachloride. The 
Biochemical journal 174: 461-467, 1978. 
24. Gesek FA, and Schoolwerth AC. Insulin increases Na(+)-H+ exchange activity 
in proximal tubules from normotensive and hypertensive rats. The American journal of 
physiology 260: F695-703, 1991. 
25. Guder WG, and Schmidt U. The localization of gluconeogenesis in rat nephron. 
Determination of phosphoenolpyruvate carboxykinase in microdissected tubules. Hoppe-
Seyler's Zeitschrift fur physiologische Chemie 355: 273-278, 1974. 
26. Gullans SR, Brazy PC, Dennis VW, and Mandel LJ. Interactions between 
gluconeogenesis and sodium transport in rabbit proximal tubule. The American journal of 
physiology 246: F859-869, 1984. 
27. Gutman AB, and Yue TF. Urinary Ammonium Excretion in Primary Gout. The 
Journal of clinical investigation 44: 1474-1481, 1965. 
28. Hansen WR, Barsic-Tress N, Taylor L, and Curthoys NP. The 3'-
nontranslated region of rat renal glutaminase mRNA contains a pH-responsive stability 
element. The American journal of physiology 271: F126-131, 1996. 
29. Hanson RW, and Reshef L. Regulation of phosphoenolpyruvate carboxykinase 
(GTP) gene expression. Annual review of biochemistry 66: 581-611, 1997. 
30. Henneman PH, Wallach S, and Dempsey EF. The metabolism defect 
responsible for uric acid stone formation. The Journal of clinical investigation 41: 537-
542, 1962. 
31. Honegger KJ, Capuano P, Winter C, Bacic D, Stange G, Wagner CA, Biber 
J, Murer H, and Hernando N. Regulation of sodium-proton exchanger isoform 3 
 77
(NHE3) by PKA and exchange protein directly activated by cAMP (EPAC). Proceedings 
of the National Academy of Sciences of the United States of America 103: 803-808, 2006. 
32. Hwang JJ, and Curthoys NP. Effect of acute alterations in acid-base balance on 
rat renal glutaminase and phosphoenolpyruvate carboxykinase gene expression. The 
Journal of biological chemistry 266: 9392-9396, 1991. 
33. Iynedjian PB, Ballard FJ, and Hanson RW. The regulation of 
phosphoenolpyruvate carboxykinase (GTP) synthesis in rat kidney cortex. The role of 
acid-base balance and glucocorticoids. The Journal of biological chemistry 250: 5596-
5603, 1975. 
34. Jaeger P, Karlmark B, and Giebisch G. Ammonium transport in rat cortical 
tubule: relationship to potassium metabolism. The American journal of physiology 245: 
F593-600, 1983. 
35. Joseph PK, and Subrahmanyam K. Effect of growth hormone, insulin, 
thyroxine and cortisone on renal gluconeogenesis. Archives of biochemistry and 
biophysics 127: 288-291, 1968. 
36. Kamel KS, Cheema-Dhadli S, and Halperin ML. Studies on the 
pathophysiology of the low urine pH in patients with uric acid stones. Kidney 
international 61: 988-994, 2002. 
37. Karim Z, Szutkowska M, Vernimmen C, and Bichara M. Renal handling of 
NH3/NH4+: recent concepts. Nephron 101: p77-81, 2005. 
38. Karinch AM, Lin CM, Meng Q, Pan M, and Souba WW. Glucocorticoids 
have a role in renal cortical expression of the SNAT3 glutamine transporter during 
chronic metabolic acidosis. American journal of physiology 292: F448-455, 2007. 
39. Karinch AM, Lin CM, Wolfgang CL, Pan M, and Souba WW. Regulation of 
expression of the SN1 transporter during renal adaptation to chronic metabolic acidosis in 
rats. American journal of physiology 283: F1011-1019, 2002. 
40. Khatchadourian J, Preminger GM, Whitson PA, Adams-Huet B, and Pak 
CY. Clinical and biochemical presentation of gouty diathesis: comparison of uric acid 
versus pure calcium stone formation. The Journal of urology 154: 1665-1669, 1995. 
 78
41. Kida K, Nakajo S, Kamiya F, Toyama Y, Nishio T, and Nakagawa H. Renal 
net glucose release in vivo and its contribution to blood glucose in rats. The Journal of 
clinical investigation 62: 721-726, 1978. 
42. Klisic J, Hu MC, Nief V, Reyes L, Fuster D, Moe OW, and Ambuhl PM. 
Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid 
dependence. American journal of physiology 283: F532-539, 2002. 
43. Laghmani K, Preisig PA, Moe OW, Yanagisawa M, and Alpern RJ. 
Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic 
metabolic acidosis. The Journal of clinical investigation 107: 1563-1569, 2001. 
44. Laterza OF, and Curthoys NP. Specificity and functional analysis of the pH-
responsive element within renal glutaminase mRNA. American journal of physiology 
278: F970-977, 2000. 
45. Laterza OF, Hansen WR, Taylor L, and Curthoys NP. Identification of an 
mRNA-binding protein and the specific elements that may mediate the pH-responsive 
induction of renal glutaminase mRNA. The Journal of biological chemistry 272: 22481-
22488, 1997. 
46. Levin BE, Finnegan M, Triscari J, and Sullivan AC. Brown adipose and 
metabolic features of chronic diet-induced obesity. The American journal of physiology 
248: R717-723, 1985. 
47. Levin BE, Hogan S, and Sullivan AC. Initiation and perpetuation of obesity and 
obesity resistance in rats. The American journal of physiology 256: R766-771, 1989. 
48. Levin BE, and Keesey RE. Defense of differing body weight set points in diet-
induced obese and resistant rats. The American journal of physiology 274: R412-419, 
1998. 
49. Levin BE, Triscari J, Hogan S, and Sullivan AC. Resistance to diet-induced 
obesity: food intake, pancreatic sympathetic tone, and insulin. The American journal of 
physiology 252: R471-478, 1987. 
50. Liu Z, Chen Y, Mo R, Hui C, Cheng JF, Mohandas N, and Huang CH. 
Characterization of human RhCG and mouse Rhcg as novel nonerythroid Rh 
glycoprotein homologues predominantly expressed in kidney and testis. The Journal of 
biological chemistry 275: 25641-25651, 2000. 
 79
51. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal 
K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, 
Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, 
Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, 
Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, 
and Hong Y. Heart disease and stroke statistics--2009 update: a report from the 
American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 
Circulation 119: e21-181, 2009. 
52. Lupianez JA, Dileepan KN, and Wagle SR. Interrelationship of somatostatin, 
insulin, and calcium in the control of gluconeogenesis in kidney cortex slices. 
Biochemical and biophysical research communications 90: 1153-1158, 1979. 
53. Maalouf NM, Cameron MA, Moe OW, and Sakhaee K. Novel insights into the 
pathogenesis of uric acid nephrolithiasis. Current opinion in nephrology and 
hypertension 13: 181-189, 2004. 
54. Madison LL, and Seldin DW. Ammonia excretion and renal enzymatic 
adaptation in human subjects, as disclosed by administration of precursor amino acids. 
The Journal of clinical investigation 37: 1615-1627, 1958. 
55. McKinney TD, and Davidson KK. Effect of potassium depletion and protein 
intake in vivo on renal tubular bicarbonate transport in vitro. The American journal of 
physiology 252: F509-516, 1987. 
56. Meydan N, Barutca S, Caliskan S, and Camsari T. Urinary stone disease in 
diabetes mellitus. Scandinavian journal of urology and nephrology 37: 64-70, 2003. 
57. Moret C, Dave MH, Schulz N, Jiang JX, Verrey F, and Wagner CA. 
Regulation of renal amino acid transporters during metabolic acidosis. American journal 
of physiology 292: F555-566, 2007. 
58. Nagami GT. Effect of bath and luminal potassium concentration on ammonia 
production and secretion by mouse proximal tubules perfused in vitro. The Journal of 
clinical investigation 86: 32-39, 1990. 
59. Nonoguchi H, Takehara Y, and Endou H. Intra- and inter-nephron 
heterogeneity of ammoniagenesis in rats: effects of chronic metabolic acidosis and 
potassium depletion. Pflugers Arch 407: 245-251, 1986. 
 80
60. Nowik M, Lecca MR, Velic A, Rehrauer H, Brandli AW, and Wagner CA. 
Genome-wide gene expression profiling reveals renal genes regulated during metabolic 
acidosis. Physiological genomics 32: 322-334, 2008. 
61. Owen EE, and Robinson RR. Amino acid extraction and ammonia metabolism 
by the human kidney during the prolonged administration of ammonium chloride. The 
Journal of clinical investigation 42: 263-276, 1963. 
62. Owen OE, Felig P, Morgan AP, Wahren J, and Cahill GF, Jr. Liver and 
kidney metabolism during prolonged starvation. The Journal of clinical investigation 48: 
574-583, 1969. 
63. Pak CY, Sakhaee K, and Fuller C. Successful management of uric acid 
nephrolithiasis with potassium citrate. Kidney international 30: 422-428, 1986. 
64. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, and Frawley WH. 
Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney international 60: 757-
761, 2001. 
65. Pithon-Curi TC, De Melo MP, and Curi R. Glucose and glutamine utilization 
by rat lymphocytes, monocytes and neutrophils in culture: a comparative study. Cell 
biochemistry and function 22: 321-326, 2004. 
66. Rapoport A, Crassweller PO, Husdan H, From GL, Zweig M, and Johnson 
MD. The renal excretion of hydrogen ion in uric acid stone formers. Metabolism: clinical 
and experimental 16: 176-188, 1967. 
67. Remer T, and Manz F. Estimation of the renal net acid excretion by adults 
consuming diets containing variable amounts of protein. The American journal of clinical 
nutrition 59: 1356-1361, 1994. 
68. Rogers S, Gavin JR, 3rd, and Hammerman MR. Phorbol esters inhibit 
gluconeogenesis in canine renal proximal tubular segments. The American journal of 
physiology 249: F256-262, 1985. 
69. Sakhaee K, Adams-Huet B, Moe OW, and Pak CY. Pathophysiologic basis for 
normouricosuric uric acid nephrolithiasis. Kidney international 62: 971-979, 2002. 
70. Sakhaee K, Nicar M, Hill K, and Pak CY. Contrasting effects of potassium 
citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-
forming salts. Kidney international 24: 348-352, 1983. 
 81
71. Sastrasinh S, and Sastrasinh M. Renal mitochondrial glutamine metabolism 
during K+ depletion. The American journal of physiology 250: F667-673, 1986. 
72. Sclafani A, and Springer D. Dietary obesity in adult rats: similarities to 
hypothalamic and human obesity syndromes. Physiology & behavior 17: 461-471, 1976. 
73. Sechi LA. Mechanisms of insulin resistance in rat models of hypertension and 
their relationships with salt sensitivity. Journal of hypertension 17: 1229-1237, 1999. 
74. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction 
method. Scandinavian journal of clinical and laboratory investigation 17: 381-387, 1965. 
75. Solbu TT, Boulland JL, Zahid W, Lyamouri Bredahl MK, Amiry-
Moghaddam M, Storm-Mathisen J, Roberg BA, and Chaudhry FA. Induction and 
targeting of the glutamine transporter SN1 to the basolateral membranes of cortical 
kidney tubule cells during chronic metabolic acidosis suggest a role in pH regulation. J 
Am Soc Nephrol 16: 869-877, 2005. 
76. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, and Curhan GC. Time 
trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney 
international 63: 1817-1823, 2003. 
77. Sundberg BE, Waag E, Jacobsson JA, Stephansson O, Rumaks J, Svirskis S, 
Alsio J, Roman E, Ebendal T, Klusa V, and Fredriksson R. The evolutionary history 
and tissue mapping of amino acid transporters belonging to solute carrier families 
SLC32, SLC36, and SLC38. J Mol Neurosci 35: 179-193, 2008. 
78. Tannen RL. Relationship of renal ammonia production and potassium 
homeostasis. Kidney international 11: 453-465, 1977. 
79. Taylor EN, Stampfer MJ, and Curhan GC. Diabetes mellitus and the risk of 
nephrolithiasis. Kidney international 68: 1230-1235, 2005. 
80. Tong J, Harrison G, and Curthoys NP. The effect of metabolic acidosis on the 
synthesis and turnover of rat renal phosphate-dependent glutaminase. The Biochemical 
journal 233: 139-144, 1986. 
81. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, and Pisani E. 
Increase in the prevalence of symptomatic upper urinary tract stones during the last ten 
years. European urology 37: 23-25, 2000. 
 82
82. Verlander JW, Miller RT, Frank AE, Royaux IE, Kim YH, and Weiner ID. 
Localization of the ammonium transporter proteins RhBG and RhCG in mouse kidney. 
American journal of physiology 284: F323-337, 2003. 
83. Vinay P, Gougoux A, and Lemieux G. Isolation of a pure suspension of rat 
proximal tubules. The American journal of physiology 241: F403-411, 1981. 
84. Welbourne TC. Interorgan glutamine flow in metabolic acidosis. The American 
journal of physiology 253: F1069-1076, 1987. 
85. Wesson DE, Nathan T, Rose T, Simoni J, and Tran RM. Dietary protein 
induces endothelin-mediated kidney injury through enhanced intrinsic acid production. 
Kidney international 71: 210-217, 2007. 
86. Wild S, Roglic G, Green A, Sicree R, and King H. Global prevalence of 
diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 27: 1047-
1053, 2004. 
87. Wu MS, Biemesderfer D, Giebisch G, and Aronson PS. Role of NHE3 in 
mediating renal brush border Na+-H+ exchange. Adaptation to metabolic acidosis. The 
Journal of biological chemistry 271: 32749-32752, 1996. 
88. Yanez AJ, Nualart F, Droppelmann C, Bertinat R, Brito M, Concha, II, and 
Slebe JC. Broad expression of fructose-1,6-bisphosphatase and phosphoenolpyruvate 
carboxykinase provide evidence for gluconeogenesis in human tissues other than liver 
and kidney. Journal of cellular physiology 197: 189-197, 2003. 
 
 
 
 
 
 
 
  
 
 
 
 83
 
VI. Characterization of a novel ENU-mutated mouse model of SNAT3 (Slc38a3)  
 
VI.1 Introduction 
 
N-ethyl-N-nitrosourea (ENU) is a chemical widely used in murine mutagenesis 
models to induce random changes in single nucleotides by alkylation of nucleic acids 
(63).  It is injected into male mice, inducing changes in spermatogonial stem cells.  Male 
mice are subsequently bred with wildtype females, and can produce countless litters.   
ENU mutagenesis is an efficient method of causing loss-of-function mutations in mice.   
There are many advantages to using ENU mutagenesis.  The occurrence of ENU 
mutagenesis-derived single nucleotide polymorphisms (SNPs) is approximately 100 
times higher than spontaneous mutations, making ENU mutagenesis a useful tool in the 
laboratory in order to rapidly screen many genes.  Additionally, the mutagenesis occurs 
in spermatogonial stem cells, allowing treated males to continue to breed and generate 
mutated offspring (55, 117).  ENU mutagenesis can induce one new loss-of-function 
mutation in every 700 gametes of ENU-treated male mice (55).  Of importance, this form 
of mutagenesis is a useful way to learn more about already discovered genes, or to 
identify new genes in an unbiased fashion based on phenotype alone (12).  ENU 
mutagenesis simulates mutations that would otherwise occur naturally, and give rise to 
better understanding of how SNPs can regulate gene function (106). 
As with many murine mutagenesis models, there are some disadvantages and 
limitations in using ENU mutagenesis for phenotyping.  It is at times difficult to assess a 
mutant phenotype as opposed to simply a normal variant, and analysis must be performed 
in numerous mice to insure the phenotype is legitimate (12).  Additionally, analyses of 
multifaceted neurological or behavioral phenotypes are relatively difficult and require 
prudence and many phenotypic variants are often missed at first glance (12, 87).  Further, 
the likelihood of identifying more than one mutation for a particular phenotype increases 
using ENU mutagenesis.  In such cases, it is important to backcross the mutant strain 
over several generations to “dilute” possible bystander mutations. . 
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For this study, we used a novel ENU-mutagenesis murine model expressing the 
mutation “SLC38a3-Q263X” (Stoeger, C; Ingenium Pharmaceuticals AG, Germany).  
The aim of this portion of the study was to characterize SNAT3 in various murine tissues 
and to understand the role of SNAT3 in vivo.                          
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VI.2 Material and methods 
 
Animals 
Male mice were treated with the potent mutagen, N-ethyl-N-nitrosourea (ENU), 
resulting in offspring carrying a single nucleotide polymorphism.  This mutation was a 
“C” to “T” mutation, known as “SLC38a3-Q263X”, causing a premature stop codon 
deleting the second half of the protein.  The breeding scheme included back-crossing over 
4 - 7 generations into C57BL/6J mice.  Pups were sacrificed after intraperitoneal injection 
of ketamine/xylazine (n=52) at postnatal day 15-18.  Organs were removed and 
immediately flash-frozen for further analysis.  Blood and spot urine was collected.  Pups 
had not yet been weaned from their mothers, and were housed in climate controlled and 
12 h light-cycled rooms.  All animal experiments were conducted according to the Swiss 
animal welfare laws and approved by the Swiss local animal authority, Zurich, 
Switzerland.       
Genotyping 
Tail clippings were made and genomic DNA was extracted for genotyping.  
Genomic DNA was sent for initial sequencing to confirm primer specificity (Microsynth, 
Balgach, Switzerland).  Mice were subsequently genotyped using the tetra-primer 
ARMS-PCR method, used specifically to identify single nucleotide polymorphisms using 
a Biometra TGradient thermocycler (Goettingen, Germany) (154).  This method employs 
a two primer pair system to identify two different alleles, for example, the “C” or “T” 
nucleotide.  The pair of inner primers recognizes two deliberate mismatches; one located 
at the 3’ terminal base of the inner primer and the template, and the other located two 
positions from the 3’ terminus.  PCR products (30 ng) were loaded onto a 12% DNA 
polyacrylamide gel and run at 90 mV.  Gels were incubated with the nucleic acid stain, 
Gel-RedTM (Biotium, Hayward, CA, USA) and visualized under UV light.  Alleles were 
easily identified and distinguishable as single bands; “T” allele was visualized at 194 kb, 
while the “C” allele was visualized at 172 kb.  Outer primers, identifying the entire target 
sequence were visualized at 309 kb.  
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 Quantitative Real-time RT PCR 
Previously frozen kidneys were homogenized using a Rotor-stator homogenizer, 
and RNA was immediately extracted using Qiagen RNeasy Mini Kit (Qiagen; Hilden, 
Germany).  DNase digestion was performed using the RNase-free DNase Set (Qiagen; 
Hilden, Germany).  Total RNA extractions were analyzed using the NanoDrop ND-1000 
spectophotometer (Wilmington, DE, USA).  cDNA was prepared from diluted RNA 
samples (100 ng/µl) using the TaqMan Reverse Transcriptase Reagent Kit containing 
10X RT buffer, MgCl2, random hexamers, dNTPs, RNase inhibitors and Multiscribe 
reverse transcription enzyme (Applied Biosystems/Roche; Forster City, CA, USA). 
Thermocycling conditions for reverse transcription were set at 25ºC for 10 min, 48ºC for 
30 min, and 95ºC for 5 min (Biometra TGradient thermocycler, Goettingen, Germany).  
Real-time RT-PCR was used to determine relative mRNA expression (7500 Fast Real-
Time PCR system, Applied Biosystems).  Thermocycling conditions were set at: 50ºC (2 
min), 95ºC (10 min), 95ºC (15 sec; 40 cycles) and 60ºC (1 min).  Forward and reverse 
primer concentration was 25 µM; probe concentration was 5 µM.  TaqMan Universal 
PCR master mix 2X (Applied Biosystems/Roche) was used as the Taq polymerase.  
Primers and probes for SNAT3, SNAT2, arginase II, phosphate-dependent glutaminase 
(PDG), phosphoenolpyruvate carboxykinase (PEPCK), Rhesus glycoprotein (Rhcg) and 
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) were generated using the 
Primer Express software from Applied Biosystems and synthesized at Microsynth 
(Balgach, Switzerland) as described previously (91, 102).  The primer and probe 
sequences for Rhcg: 5’-GTT GGA GAA GAA GCG CAA GAA-3’, forward; 5’-CGA 
AGA CCA TGG CGT GTA CA-3’, reverse; 5’-TTA CTA TCG CTA CCC GAG CTT 
CCA G-3’, probe.  Probes were generated with the reporter dye FAM at the 5’ end and 
TAMRA at the 3’ end.  Each sample was run in triplicate including a negative control 
(without Multiscribe reverse transcription enzyme).  The cycle threshold (Ct) values 
obtained were ultimately compared to Ct values of the endogenous gene HPRT.  Relative 
mRNA expression ratios were calculated as R=2[Ct(HPRT)-Ct(gene of interest)].   
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Immunoblotting 
Total membrane and cytosolic protein preparations were prepared from whole, 
non-perfused kidney and liver using a K-HEPES buffer composed of 200 mM mannitol, 
80 mM HEPES, 41 mM KOH, along with the protease inhibitors, PMSF, K-EDTA, and 
leupeptin (pH 7.5).  Organs were homogenized in 200 µl of ice-cold K-HEPES buffer 
using a tip sonicator and immediately centrifuged at 2000 rpm for 20 min (4ºC).  The 
supernatant was aspirated and placed in an ultracentrifuge (Sorvall, Thermo Fischer 
Scientific) for 1 h at 41,000 rpm 4ºC.  The supernatant containing cytosolic protein from 
this second centrifugation step was removed and the pellet containing membrane protein 
was resuspended in K-HEPES buffer and sonicated to evenly distribute proteins.  The 
BioRad Dc Protein assay was used to measure protein concentration (Bio-Rad; Hercules, 
CA, USA).  Total membrane (75 µg) or cytosolic (50 µg) protein containing Laemmli 
sample buffer and loaded onto a 10% polyacrylamide gel and SDS-PAGE was 
performed.  Proteins were transferred to polyvinylidene difluoride membranes (PVDF; 
Immobilon-P, Millipore, Bedford, MA, USA).  Membranes were blocked with Tris-
buffered saline / 0.1% Tween and 5% non-fat dry milk for 1 h.  Primary antibodies were 
applied for 2 h at RT or overnight at 4ºC.  The primary antibodies used for this study 
were: phosphate-dependent glutaminase (PDG), which recognizes both the rat (KGA) 
and human (GAC) kidney-type isoforms of PDG forming the mature PDG protein (66 
and 68 kDa; a kind gift from N. Curthoys, Colorado State University, USA; diluted 
1:500) (33); anti-PEPCK polyclonal antibody (63 kDa; Cayman Chemical, Ann Arbor, 
MI, USA; diluted 1:1,000), and mouse monoclonal antibody against β-actin (42 kDa; 
Sigma, St. Louis, MO, USA; diluted 1:5,000).  The anti-Slc38a3 antibody (1:500) was 
generated as previously described (91).  The glutamine synthetase antibody was detected 
at 45 kDa and diluted 1:5000.  The secondary antibodies used were donkey anti-rabbit 
horseradish peroxidase conjugated diluted 1:12,000, anti-rabbit alkaline phosphatase 
conjugated diluted 1:5,000, and anti-mouse IgG alkaline phosphatase conjugated diluted 
1:5,000.  After a series of washing steps and blocking, membranes were treated with 
alkaline phosphatase or horseradish peroxidase conjugated developing solution and 
exposed to the Diana III chemiluminescence detection system (Raytest).  Specific bands 
on PVDF membranes were later quantified using AIDA Image analyzer version 3.44.  
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Membranes were stripped and reprobed for anti-β-actin and subsequent analysis of the 
protein of interest was determined relative to β-actin quantification and reported as 
relative protein abundance (ratio of β-actin/protein of interest).  
 
Immunohistochemistry 
For immunohistochemical studies on kidney, liver and brain slices, mice were 
perfused through the left ventricle with phosphate-buffered saline (PBS) followed by a 
paraformaldehyde-cacodylate fixative containing a mixture of three buffers: 1) a sodium-
cacodylate-Sucrose buffer (100 mM sodium-cacodylate, 100 mM sucrose); 2) a sodium-
cacodylate-HAES fixative containing (60% of final volume of buffer 1, 40% HAES-10%, 
3.24 mM MgCl2 x 6 H2O, 4.36 mM picric acid) and a 3) 25% paraformaldehyde solution 
(final concentration 3%), pH 7.4).  Organs were flushed with PBS, removed, cut into 
slices, washed three times with PBS, and frozen in liquid propane cooled with liquid 
nitrogen.  The immunostaining procedure was carried out as previously described (131).  
Briefly, 5 µm cryosections were incubated with 0.5% SDS for 5 min, washed three times 
with PBS, and incubated with PBS containing 1% BSA for 15 min before application of 
the primary antibodies.  The primary antibodies (rabbit anti-SNAT3 affinity purified 
1:200 (91), goat anti 4F2hc 1:400, Santa Cruz Biotechnology, CA, USA) were diluted in 
PBS and applied either for 75 min at RT or overnight at 4°C.  Sections were washed 
twice with PBS + 2.7% NaCl for 5 min, once with PBS, and incubated for 1 h at RT with 
their respective secondary antibodies (donkey anti-rabbit Alexa 594 and donkey anti-goat 
Alexa 488 diluted 1:1000, Invitrogen, Basel, Switzerland).  Sections were then washed 
twice with PBS + 2.7% NaCl and once with PBS before mounting with Dako Glycergel 
Mounting Media (Dako North America Inc., Carpenteria, CA, USA).  All sections were 
viewed using a confocal microscope (Leica CLSM). Pictures were overlaid using Adobe 
Photoshop software. 
 
Brush border membrane preparations and acridine orange quenching experiments 
Kidney brush border membrane preparations were prepared as previously 
described (90).  Briefly, (perfused/ non-perfused) kidneys were cut into small sections 
and homogenized using a Polytron homogenizer with a fine rod for 2 minutes in a buffer 
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containing: 300 mM mannitol, 5 mM EGTA and 12 mM Tris-HCl, pH 7.1.  A fraction of 
the homogenates was stored at -20 ºC for immunoblotting, while 1 M MgCl2 was added 
to the remaining homogenate and allowed to precipitate on ice for 15 minutes.  The 
sample was then centrifuged at 4500 rpm for 15 minutes.  The supernatant was aspirated 
and centrifuged at 18000 rpm for 30 minutes.  The pellet was resuspended in membrane 
buffer consisting of: 300 mM mannitol, 20 mM HEPES-Tris, pH 7.4.  The resuspended 
samples were then centrifuged at 18500 rpm for 30 minutes.  Brush border membrane 
vesicles were resuspended in vesicle buffer containing: 280 mM mannitol, 5 mM 
MES/N-methyl-D-glutamine and 2 mM MgCl2, pH 5.5.  Protein concentration was 
measured using the BioRad fast method. 
Acridine orange quenching measurements were performed as previously 
described (56).  Briefly, BBMV suspensions (30 µl) and 6 µM of acridine orange dye 
were added to a spectrofluometer cuvette held at 25ºC.  Excitation occurred at 493 nm 
and emission at 530 nm.  NHE activity was calculated as the as the ∆ pH per minute over 
Q, where Q represents the quenching of acridine orange detected upon addition of sodium 
gluconate to the cuvette (2 M). 
Statistical analyses were performed using unpaired Student’s t-test, and results 
with p ≤ 0.05 were considered statistically significant.  Data are presented as means ± 
SEM. 
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VI.3 Preliminary results 
 
After back-crossing mice between 4-7 generations, pups (n= 52) were sacrificed 
on postnatal-day 15-18 and tail clips were taken for genotyping mice.  The target 
sequences are shown in figure 1 A.  ENU-mutagenesis produced a “C” to “T” mutation in 
offspring, which was clearly detected using a tetra-primer ARMS-PCR genotyping 
system and DNA polyacrylamide electrophoresis (figure 1 B).   To confirm our 
genotyping results, samples were sent to Microsynth (Balgach, Switzerland) for 
sequencing of genomic DNA (figure 2 A-C).  The sequencing data was visualized using 
Chromas software (Technelysium Pty Ltd). Analysis of a small number of pups suggests 
that the ratio of genotypes obtained follows Mendelian inheritance. 
 Male Female 
Wildtype  n = 4 (19 %) n = 4(13 %) 
Heterozygous n =12(57 %) n = 17(55 %) 
Mutant n = 5(24 %) n = 10(32 %) 
Table 1. Gene distribution between genders.   
 
SNAT3 protein is undetectable in kidney and liver of mutant mice 
 Whole, non-perfused kidney and liver samples were homogenized in preparation 
for immunoblotting or RNA extraction and quantitative real-time RT-PCR.  Using both 
C-(not shown) and N-terminal antibodies, we were unable to detect SNAT3 protein in the 
kidney or liver samples of mutant mice, demonstrating that the mutation indeed leads to 
ablation of the SNAT3 protein (figure 3 B and 4 B, respectively).  On the mRNA level, 
renal SNAT3 mRNA expression was significantly reduced in mutant mice in comparison 
to littermates (figure 3 A).  Similarly, SNAT3 mRNA expression in liver samples of 
mutant mice was minimal, while wildtype and heterozygous mice showed strong 
expression (figure 4 A). 
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Phenotyping SNAT3 mutant mice 
Once genotyping results were confirmed, phenotypic analysis could be 
performed.   Mutant mice were easily distinguishable by eye; they were growth retarded 
and displayed mild forms of ataxia and neurological disturbances (unpublished 
observations).  Mutant mice weighed significantly less than their wildtype or 
heterozygote littermates (figure 5 A).  After postnatal day 15-18, spot urines were 
collected, and mice were sacrificed; blood and organs were removed and immediately 
flash frozen for further analysis.  Mean relative organ weights were taken in comparison 
to body weight.  Mean relative kidney weight was comparable among littermates.  Mean 
relative brain weight was significantly larger and mean relative liver weight significantly 
smaller in mutants in comparison to both wildtype and heterozygous littermates (figure 5 
B). 
 
SNAT3 deletion causes reduced urinary ammonia and urea excretion and elevated serum 
urea in mutant mice 
Urine samples were obtained as spot urines, given that it is impossible to collect 
24 h urine samples from two-week old pups.  Spot urine was analyzed for urinary NH4+ 
and urea concentration.  Serum urea was also analyzed from blood samples collected 
upon sacrifice of animals.  Urinary NH4+ excretion was significantly reduced in mutant 
mice in comparison to both wildtype and heterozygous mice (figure 6).  Urinary urea in 
mutants decreased in parallel (figure 7 A).  Serum urea, on the other hand, increased 
substantially in mutant mice relative to littermates (figure 7 B).   
 
PDG and PEPCK are not affected by SNAT3 deletion 
 mRNA expression of PDG and PEPCK were determined in kidney samples taken 
from wildtype, heterozygous or mutant mice.  Renal PDG and PEPCK mRNA expression 
was unremarkable among groups, however differences were observed after 
immunoblotting for PDG (figure 8 A-C).  Mutant mice appear to express more PDG 
protein than wildtype or heterozygous mice (figure 8 C), while PEPCK remained 
unchanged among littermates. 
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 Mutant mice exhibit enhanced mRNA expression of liver glutamine synthetase 
 Liver samples were prepared for quantitative real-time RT-PCR.  Glutamine 
synthetase is an important enzyme involved in the conversion of glutamate and ammonia 
to glutamine in the liver during ammonia detoxification.  Mutant mice showed strong 
upregulation of glutamine synthetase (Glu1) mRNA in comparison to wildtype and 
heterozygous littermates (figure 9 A).  Glu1 protein was detected in all groups by 
immunoblotting, however no changes were observed among littermates (figure 9 B).   
 
Compensatory glutamine transporting mechanisms are not present in SNAT3 mutant 
mice 
SNAT2, a member of System A transport, is highly expressed in the kidney and 
could potentially compensate for the loss of SNAT3 function in mutant mice.  We tested 
kidney samples for SNAT2 mRNA expression, and could not detect changes among 
wildtype, heterozygous, or mutant mice (figure 10 A).   
To rule out changes in distal tubule NH4+ handling, mRNA expression of the 
Rhesus glycoprotein, Rhcg, was examined in all mice.  Rhcg is primarily expressed in the 
connecting tubule and the collecting duct, and plays an important role in apical NH4+ 
extrusion into the final urine (13, 22) .  Mutant mice did not show changes in renal 
mRNA expression of Rhcg, in comparison to wildtype or heterozygous mice (figure 10 
B). 
      
Heterozygous mice show differences in ammonium handling after an acid challenge 
Differences in SNAT3 protein abundance were observed in both kidney and liver 
samples of heterozygote and wildtype mice, which prompted further investigation.  We 
sought to determine if, under control conditions or after an acid challenge, heterozygote 
mice exhibited any differences in comparison to wildtype mice.  Wildtype and 
heterozygote mice were placed in metabolic cages, and mice were divided into acid-
loaded groups.  The acid load consisted of 0.28 M NH4Cl added to the drinking water for 
48 h.  Urine was collected and kidneys harvested upon sacrifice.   
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Both wildtype and heterozygous mice, with or without an acid load, showed 
appropriate responses to the acid challenge; total urinary NH4+ excretion increased while 
urinary pH decreased (figure 11, A-C).  
 On the mRNA level, renal SNAT3, PDG and PEPCK were significantly 
enhanced in heterozygote mice after acid-loading in comparison to wildtype mice.  This 
observation suggests that perhaps heterozygous mice compensate for the partial defect in 
the SNAT3 protein by upregulation of SNAT3, PDG and PEPCK mRNA expression 
(figure 12 A-C).   
It has been previously shown that Na+/H+ exchanger isoform 3 (NHE3) is present 
on the apical brush border membrane of renal proximal tubule cells, and is critical for 
luminal NH4+ transport.  We sought to determine if heterozygote mice exhibited altered 
NHE3 activity in comparison to wildtype mice, in the presence or absence of an acid-
challenge.  Brush border membrane vesicle acridine orange quenching experiments were 
performed.  We observed a significant increase in NHE3 activity in acid-loaded 
heterozygous mice in comparison to controls (figure 13).   
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VI.4 Discussion  
 
The preliminary results of this SNAT3 mutant study reveal interesting findings 
regarding the role and regulation of SNAT3 in vivo.  Deletion of SNAT3 is lethal.  
Mutants die within the first 3 weeks after birth, and appear to suffer from severe 
neurological disturbances.  Our data suggest that SNAT3 plays a significant role in the 
regulation of glutamine flux in kidney and liver and most likely brain, since major defects 
were observed on the functional level.  
SNAT3 is highly expressed in brain astrocytes, and is purported to play a role in 
the glutamine-glutamate cycling involved in neurotransmission (15, 25).  The lethargy 
and altered, uncoordinated gait observed in mutant mice could largely be due to SNAT3 
deletion in the brain, affecting neurotransmission.  Preliminary immunohistochemical 
studies revealed SNAT3-related staining in wildtype and heterozygous but not mutant 
brain slices (not shown).  Further studies will be performed in order to more accurately 
localize SNAT3 in brain tissue, as well as identify other transport mechanisms that could 
be compensatory in these animals, such localization and expression of the glial glutamate 
transporter EAAT2, the neuronal glutamate transporter excitatory amino acid carrier-1 
EAAC1, and other glutamine transporting members of the SLC38 family.   
SNAT3 deletion in the kidney reveals important regulatory roles of SNAT3 in 
renal ammoniagenesis and gluconeogenesis.  We and others have shown that SNAT3 
mRNA and protein increase in response to metabolic acidosis (25, 68, 91, 102, 127).  
These studies show strong evidence that SNAT3 is an important glutamine influx 
mechanism in proximal tubule cells for ammoniagenesis.  Our mutant mice clearly show 
reduced urinary NH4+ excretion, indicative of a reduced capacity either to generate or 
excrete NH4+.  The fact that there are no compensatory changes in SNAT2 mRNA, (a 
glutamine transporter highly expressed in the kidney), suggests that changes in this 
transporter do not account for changes observed in urinary NH4+ excretion, and implies 
that SNAT3 is crucial for renal ammoniagenesis.  Enhanced glutamine transport via 
SNAT3 would stimulate increases in PDG expression and activity, (as we have 
previously shown in both Aim I and II) enhancing ammoniagenesis, while generating 
more available substrate for gluconeogenesis (α-ketoglutarate).  Increased α-
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ketoglutarate, subsequently in the presence of PEPCK, produces both glucose and 
bicarbonate.  We did not, however, observe changes in PDG and PEPCK on mRNA 
level.  PDG protein in mutant mice did appear to be enhanced.  Changes in mRNA 
stabilization could account for upregulation of PDG protein in mutants; however, this 
remains to be examined. 
It would be interesting to examine changes in other rate-limiting gluconeogenic 
enzymes, such as fructose 1,6-bisphosphatase and fructose 2,6-bisphosphatase (FBP1 and 
FBP2, respectively).  FBP1 catalyzes the conversion of fructose 1,6-bisphosphate to 
fructose 6-phosphate and inorganic phosphate, and has been recently immunolocalized to 
PT cells in human kidney (153).  In Aim II, we discussed changes in both FBP1 and 
FBP2 in obese-glucose intolerant (O-GI) mice after an acid challenge, revealing 
regulation of both enzymes.  These studies are planned in wildtype, heterozygous and 
mutant kidneys.   
A distal defect NH4+ excretion, particularly secondary to changes in the 
expression of the Rhesus glycoprotein, Rhcg, could be another compensatory mechanism 
for SNAT3 mutant mice.  Rhcg, however, was unchanged in mutant mice, further 
supporting our hypothesis that SNAT3 is the important regulatory mechanism in NH4+ 
handling.   
Further, the kidney plays a role in the excretion of urea generated by the liver 
during NH4+ detoxification.   Urea is both reabsorbed and secreted in the kidney.  Mutant 
mice show significantly reduced urinary urea excretion, relative to wildtype and 
heterozygous littermates.  Based on our results, we are unable to confirm whether the 
primary defect lies in hepatic urea production or the renal transport/absorption of urea.  
Further, the physiological status of the mouse at the time of urine collection could also 
play a role.  Several isoforms of the epithelial urea transporter family “UT-A” exists in 
the kidney, and reduced urea excretion could be due to changes in these transport 
mechanisms (138).  It is more likely, however, that hepatic urea production is altered, 
since SNAT3 is highly expressed in the liver and its primary role is to participate in 
glutamine influx for detoxification of NH4+ to urea (53).  We hypothesize that less 
glutamine transport into periportal hepatocytes would result in reduced NH4+ production 
from the catabolism of glutamine to glutamate in periportal hepatocyte mitochondria, and 
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thus less NH4+ available for ureagenesis (53).  Indeed, we found upregulation of arginase 
II mRNA in liver suggesting upregulation of enzymes involved in ureagenesis.  In 
parallel, lack of SNAT3 mediated efflux of glutamine into the blood from perivenous 
hepatocytes may suggest a reduction in NH4+ detoxification and glutamine synthesis from 
glutamate. More experiments, however, are required to dissect the role of SNAT3 in 
hepatocytes. 
An interesting observation in heterozygous mice led us to test whether a partial 
defect in SNAT3 could be functionally relevant during an oral acid challenge.  
Heterozygous and wildtype mice were given NH4Cl in the drinking water for 48 h to 
induce acidosis.  Heterozygous mice showed appropriate and similar changes in urinary 
pH and NH4+ excretion similar to wildtype mice.  Surprisingly, differences in regulation 
were observed on mRNA level.  Heterozygous mice showed stronger increases in 
SNAT3, PDG and PEPCK mRNA expression, suggesting that perhaps an enhancement in 
mRNA expression is part of a compensatory mechanism in these animals.  Furthermore, 
increases in NHE3 activity was observed in acid-loaded heterozygous mice which could 
reflect the need for enhanced NH4+ extrusion secondary to the increased metabolic acid 
load.  
In sum, preliminary work using our SNAT3 mutagenesis model suggests that 
SNAT3 is important in normal brain, kidney and liver function.  Further work needs to be 
done in order to characterize the exact mechanisms of the defects associated with SNAT3 
deletion.        
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VI.5 Figure legends 
Figure 1.  The genomic DNA sequences of both wildtype and mutant mice.  Mutant 
mice exhibit a single nucleotide polymorphism in the SNAT3 sequence in exon 10 where 
a “C” to “T” mutation is observed in ENU mutants leading to an early stop codon at 
position Q263X and removing the last 5 of 11 transmembrane helixes (A).  Allelic 
discrimination was easily determined among littermates using tetra-primer ARMS-PCR.  
Original 12 % DNA polyacrylamide gel imaged under UV light (B).  The “C” or 
wildtype allele had the expected band size of 194 kb, while the mutant “T” allele was 172 
kb.  Outer primer bands are not displayed.  
 
Figure 2.  Tetra-primer ARMS-PCR genotyping results were confirmed by genomic 
DNA sequencing.  Genomic DNA samples from previously genotyped mice were 
sequenced to confirm genotyping results obtained by the tetra-primer ARMS PCR 
method.  Original sequencing results from wildtype (A); homozygous mutant (B); and 
heterozygous mutant (C) mice.  Sequencing results were viewed using the Chromas 
software.   
 
Figure 3.  SNAT3 protein is not detected in mutant mice confirming deletion of the 
protein.  mRNA expression of SNAT3 was determined in kidneys using quantitative real-
time RT PCR (A).  Total membranes were extracted from whole, non-perfused kidney, 
and PVDF membranes were probed with an N-terminal antibody against SNAT3 and 
reprobed after stripping for β-actin to control for equal loading (B).  Original blots are 
depicted.  **P ≤ 0.01, *P ≤ 0.05. 
 
Figure 4.   SNAT3 is highly expressed on both mRNA and protein level in liver of 
wildtype and heterozygous mice, but is nearly absent in mutant mice.  mRNA 
expression of SNAT3 was determined in liver using quantitative real-time RT PCR (A).  
Total membranes were extracted from whole, non-perfused liver, and original blots are 
shown after being probed with an N-terminal antibody against SNAT3 and reprobed after 
stripping for β-actin to control for equal loading (B).   **P ≤ 0.01. 
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 Figure 5.   Mutant mice were smaller and exhibited changes in relative organ weights 
in comparison to wildtype and heterozygous littermates.  Mutant mice weighed 
significantly less than littermates (A).  Mean relative organ weight per gram body weight 
revealed that mutant mice had significantly larger brains and smaller livers than 
littermates (B).  Values are means ± SE of results, ***P ≤ 0.001. 
 
Figure 6.  Mutant mice show reduced urinary NH4+ excretion.  Spot urines were 
collected for NH4+ analysis.  Mutant mice showed significantly less urinary NH4+ 
excretion than wildtype or heterozygous littermates. **P ≤ 0.01, *P ≤ 0.05. 
 
Figure 7.  Mutant mice exhibit disturbances in urinary urea and serum urea values.  
Mutant mice showed significantly less urinary urea excretion in comparison to 
littermates.  Serum urea, however, was significantly increased in mutant mice, suggesting 
a defect in ureagenesis or excretion.  **P ≤ 0.01, *P ≤ 0.05.     
 
Figure 8.  PDG and PEPCK are unaltered in mutant mice on mRNA level.  mRNA 
expression of PDG and PEPCK was determined in kidney using quantitative real-time RT 
PCR (A).  Cytosolic membrane fractions were extracted from whole, non-perfused 
kidneys, and original blots are shown (B).  No differences in PDG and PEPCK mRNA 
expression were detected among groups; however, PDG protein abundance appeared to 
be slightly increased in mutant mice in comparison to wildtype and heterozygous 
littermates. 
 
Figure 9.  Glutamine synthetase mRNA is highly upregulated in mutant mice, despite 
changes in protein abundance.  mRNA expression of glutamine synthetase (A) or 
arginase II (C) was determined in liver using quantitative real-time RT PCR.  Total 
membrane fractions were extracted from whole, non-perfused livers; original blots are 
shown (B).  Glutamine synthetase mRNA was substantially upregulated in mutant mice, 
while no differences were detected on protein level.    *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 
0.001. 
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Figure 10.  Reduced ammonium excretion observed in mutant mice is not likely due to 
alterations in distal renal ammonium transport.  mRNA expression was determined in 
kidney samples using quantitative real-time RT-PCR.  mRNA expression of SNAT2 (A) 
and Rhcg (B) was unremarkable between groups. 
 
Figure 11.  Heterozygous mice show appropriate responses to an acid load.  Wildtype 
and heterozygous mice were challenged with an oral acid load, and subsequently placed 
in metabolic cages.  Both wildtype and heterozygous mice displayed appropriate 
responses to an NH4Cl load; urinary pH (A) decreased substantially in NH4Cl treated 
mice, while NH4+ excretion per 24 hour urine volume (B) and relative to creatinine (C) 
increased substantially.  **P ≤ 0.01, ***P ≤ 0.001.    
 
Figure 12.  Acid-loaded heterozygous mice showed the greatest increases in SNAT3, 
PDG and PEPCK mRNA expression in comparison to wildtype mice.  mRNA 
expression was determined in kidneys of control and acid-loaded wildtype and 
heterozygous mice using quantitative real-time RT-PCR.  Acid-challenged heterozygous 
mice showed substantial increases in SNAT3, PDG and PEPCK mRNA expression. *P ≤ 
0.05, **P ≤ 0.01, ***P ≤ 0.001. 
 
Figure 13.  Sodium/hydrogen exchange activity is increased in BBMV from acid-
loaded heterozygous mice.  BBMV preparations were made and acridine orange 
quenching experiments were performed.  Heterozygous mice given an NH4Cl load had 
enhanced NHE3 activity relative to wildtype mice suggesting that increased 
ammoniagenesis observed in these mice leads to enhanced NH4+ transport, perhaps as a 
compensatory mechanism due to the partial defect in SNAT3 in heterozygous mice.  *P ≤ 
0.05. 
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VII. Dissertation discussion 
The research presented herein describes developments in understanding the 
regulation of SNAT3 and other transporters and enzymes involved in renal 
ammoniagenesis and gluconeogenesis.  This work is a continuation of much past and 
present research in renal acid-base homeostasis and gluconeogenesis.  Three different 
studies are described in this dissertation, and are designated as specific aims; Aim I, II 
and III.  Aim I, discussed the role of SNAT3 during dietary potassium restriction, high 
protein intake and metabolic acidosis.  Using a mouse model of diet-induced obesity in 
Aim II, we were able to show regulation of SNAT3 by obesity and glucose intolerance.  
An ENU-mutagenesis model of SNAT3 was utilized in Aim III, to elucidate the 
physiological role of SNAT3 in various organ systems and during metabolic acidosis.  
Taken together, this work highlights the importance of SNAT3 in the kidney, under 
various dietary treatments, mouse models of disease and in absence of SNAT3 in vivo.     
The renal proximal tubule cell houses all the necessary machinery required to 
respond to changes in daily acid-base balance, due to localization of various transport 
proteins and enzymes, namely SNAT3, PDG and PEPCK.  Ammonium and bicarbonate 
production and excretion, coupled with proton secretion are byproducts of reactions 
involving glutamine influx via SNAT3 and activities of PDG and PEPCK; leading to the 
restoration of acid-base balance in response to an acid load.  These processes are indeed 
complex and are not fully understood.         
Evidence for a role of SNAT3 in renal acid-base balance comes from a variety of 
observations.  Renal extraction of glutamine is substantially increased during acidosis and 
is redirected from splanchnic pools to the kidney (35, 125, 149).  A specialized transport 
mechanism must be in place to support the increased glutamine usage by the kidney.  A 
dietary acid load, as observed with low K+ or high protein intake or the oral 
administration of NH4Cl, results in significant changes in proximal tubular transport 
mechanisms (61, 88, 115, 123, 135, 136, 150).  Although the mechanisms involved vary 
with different treatments, the outcome is similar; acid loading, of any variety, results in a 
remarkable increase in SNAT3 mRNA expression and protein abundance.  Localization 
of SNAT3 to the basolateral aspect of the proximal tubule cell provides support for a role 
in acid-base balance, in particular, as the glutamine influx mechanism during acidosis. 
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Low K+ or high protein intake, and metabolic acidosis generated by an oral acid 
load leads to increases in urinary NH4+ excretion with a concomitant increase in SNAT3 
abundance.  Immunohistochemical localization showed SNAT3-like staining in S1, S2 
and S3 segments in response to K+ restriction, high protein intake and acidosis.  
Cafeteria style feeding produced two cohorts of mice, based on weight and 
glucose intolerance; obese, glucose-intolerant (O-GI) mice and moderate weight, less 
glucose intolerant non-responders (NR).   Challenging both groups with an acid load 
revealed several defects in renal ammoniagenesis which were not seen at baseline.  O-GI 
mice, despite reduced NH4+ excretion and a more alkaline urinary pH, had massive 
increases in SNAT3 mRNA and protein expression in comparison to NR mice, 
suggesting potential dysregulation of SNAT3 with high-fat feeding.  Our data suggest 
that perhaps insulin, glucose intolerance or circulating free fatty acids as observed in 
obesity may play a role in regulating SNAT3 and ammoniagenesis. 
Finally, an ENU-mutagenesis model of SNAT3 revealed that deletion of this 
transporter is lethal.  Apart from reduced urinary defects such as reduced NH4+ and urea 
excretion, these mice exhibit neurological disturbances and stunted growth.  More work 
is needed to examine both brain and liver disturbances in these mice.   
In conclusion, our results show strong evidence that SNAT3 is a crucial if not the 
primary glutamine transporter, not only in the kidney, but in the brain and liver.  It 
appears to play an important role in renal ammoniagenesis and gluconeogenesis, and is 
regulated under various dietary conditions known to elicit acidosis.     
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